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ABSTRACT 
Iron deficiency is reported as the most common nutrient deficiency worldwide. Due to 
rapid growth and low iron stores at birth, infants are at particular risk for developing iron 
deficiency. Further, iron deficiency is known to affect the developing microbiota. Thus, the aim 
of this study was to determine the lasting effects of an early-life iron deficiency on physiological 
outcomes after a period of iron repletion in the diet. Forty-two intact male pigs were provided ad 
libitum access to dietary treatments including control (CONT, 21.3 mg Fe/L) or iron-deficient 
(ID, 2.72 mg Fe/L) milk replacers from postnatal day (PND) 2 to 32. From PND 33 to 61, all 
pigs were transitioned through a series of age-appropriate, iron-adequate diets. Blood was 
collected weekly from PND 7 to 28, and again on PND 35 and 56, and fecal samples and tissues 
were collected at PND 32 and/or 61. Body weight gain was reduced (P < 0.001) in ID pigs 
compared with CONT pigs before PND 32, with treatment effects remaining (P = 0.03) after 
dietary iron repletion. At PND 32, ID pigs exhibited reduced (P < 0.001) hematocrit and 
hemoglobin compared with CONT pigs, but both responses had equalized after iron repletion. 
Analysis of peripheral protein and mRNA gene expression biomarkers yielded inconclusive 
results as would be expected based on previous biomarker analyses across multiple species. 
Additionally, ID pigs exhibited increased (P < 0.001) total volatile fatty acid (VFA) 
concentrations in ascending colon and rectal contents compared with CONT pigs at PND 32, but 
differences in VFA concentrations were absent after iron repletion. In ascending colon contents, 
15 genera differed between ID and CONT pigs, while 27 genera were differentially affected in 
rectal contents. Finally, ID pigs had higher (P = 0.012) relative abundance of Lactobacillus and 
lower (P = 0.042) relative abundance of Parabacteroides in ascending colon contents compared 
with CONT pigs. In rectal contents, ID pigs had lower (P ≤ 0.05) relative abundances of
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Bacteroides, and various members of the Clostridium family including Clostridiaceae, 
Lachnospiraceae, and Ruminococcaceae. These findings suggest that early-life iron status causes 
profound shifts in growth performance and hematological outcomes, with only partial recovery 
following dietary iron repletion. Interestingly, VFA concentrations were increased in ID pigs, 
and microbial composition was shifted within the colon, though stabilization of VFA after 
receiving a common, iron-replete diet was observed. 
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  CHAPTER 1: INTRODUCTION 
It is widely accepted that iron deficiency is the most prevalent micronutrient deficiency 
worldwide. Moreover, iron deficiency affects over two billion people of all age groups, with 
young children and women of childbearing age being at increased risk (1,2). Due to their rapid 
growth, infants specifically are at particular risk for developing iron deficiency. Further, 
untreated iron deficiency can progress to iron deficiency anemia (IDA), which is one of the 
leading contributors of chronic anemia (3). In the infant, iron deficiency and IDA can develop 
from many different etiologies such as inadequate iron stores, inadequate intake of iron, and 
decreased iron absorption. It has been proven that iron deficiency during this critical time of 
development can have lasting influences on the developing neonate. As such, it is critical to 
understand the mechanisms through which iron deficiency may alter the trajectory of 
development in the neonate, as well as identifying the critical window during which iron 
repletion may be able to compensate for the effects of early life iron deficiency.  
Due to the significant impacts iron deficiency and IDA have on the developing neonate, 
the aim of this study was to determine the effects of IDA on the young piglet as a model for the 
human infant. Specifically, the effect that IDA has on hematological outcomes, growth 
performance, various biomarkers directly involved in iron metabolism, volatile fatty acids, and 
the microbiota. Further, to establish whether reversibility with iron repletion may be able to 
compensate for early-life IDA, and if this is achievable.  
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CHAPTER 2: LITERATURE REVIEW 
Iron Deficiency and Iron Deficiency Anemia 
Iron deficiency is defined as a lack of iron in the body. Iron deficiency anemia (IDA) is 
when iron deficiency is severe enough that red blood cell (RBC) production is inhibited (3). 
More specifically, in iron deficiency, normal hemoglobin values are observed, whereas serum 
transferrin and serum ferritin may be lower than established normal ranges. During ID states, 
normal physiological functions are not maintained either from lack of bioavailability, ingestion 
of less iron than the established requirement, or increased physiological requirements without an 
increase in iron intake (4). In IDA, the depletion of iron is severe enough that a reduction in 
hemoglobin values are observed in addition to decreased serum ferritin levels. Cases of iron 
deficiency and IDA are of major global concern due to high prevalence, stemming from many 
different etiologies, as well as the negative effects associated with iron deficiency and IDA, 
outlined below, that may or may not be reversible.  
There are several etiologies associated with iron deficiency worldwide, one of which is 
geographical location. In developing countries, inadequate intake of iron is a leading factor, 
whereas in developed countries the etiology varies to a greater extent depending on age and 
gender, along with a higher likelihood that digestive diseases are associated with iron deficiency 
(3). Digestive diseases contributing to iron deficiency can stem from one of two etiologies; either 
increased loss of iron, typically due to blood loss, or decreased iron absorption. Those related to 
blood loss include lesions or ulcers throughout the gastrointestinal tract (GIT), benign or 
malignant cancers, vascular malformations, such as antral vascular ectasia, the use of non-
steroidal anti-inflammatory drugs, and inflammatory bowel disease (3,5,6). Those related to 
decreased absorption of iron include atrophic gastritis and celiac disease (3,5). Iron status has 
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also been proven to play a role in non-nutritive diseases including Alzheimer’s disease, 
Parkinson’s disease, Friedreich’s ataxia, Huntington’s disease, restless leg syndrome, and 
aceruloplasminemia (iron accumulation in the brain and organs) (7). Taken together, the 
pathogenesis of iron deficiency can result from a number of etiologies, as well as occur in 
association with various nutritive and non-nutritive diseases.  
Dietary iron sources, requirements, and bioavailability 
There are many sources of dietary iron that are appropriate for all age groups, each of 
which vary in bioavailability. Dietary iron is ingested in one of two forms: heme or non-heme. 
Heme, or ferrous iron (Fe2+), is higher in animal products and represents approximately 5-10% of 
ingested iron in the adult western diet (8). Non-heme, or ferric iron  (Fe3+), is found in plant 
products and accounts for 90-95% of ingested iron (8). Non-heme iron is considered much less 
bioavailable than that of heme iron, though many factors contribute to the bioavailability of the 
ingested iron including the content found in the ingested food, what form it is in, and what the 
metabolic demands are in relation to the amount of iron already stored in the body (8,9). The 
highest sources of iron come from fortified cereals. This includes rice cereals for infants and 
breakfast cereals for toddlers through adults, as breakfast cereals are fortified with up to 100% of 
the daily iron requirement in one serving. Other sources of iron include but are not limited to 
fruits, vegetables, red meat, lentils, and beans. Overall, iron from meat sources are considered 
more bioavailable than iron from plant sources and fortified cereals, as the latter are typically 
fortified with electrolytic iron which is reported to have lower bioavailability (10). Considering 
bioavailability can have a profound effect on the amount of iron absorbed from the diet, the 
bioavailability of each source of dietary iron should be taken into consideration when 
establishing iron intake requirements. 
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It is recommended that term infants 0-6 months ingest at least 0.27 mg of iron per d from 
human milk or infant formula (11). Human milk generally contains a low concentration of iron, 
which is highly variable both within and between lactating mothers, typically ranging from 0.2 to 
0.7 µg/ml (12). However, human milk has higher bioavailability when compared with other iron 
sources (12). Iron absorption from human milk is further enhanced by lactoferrin, which is a 
milk-derived glycoprotein capable of binding two ferric iron molecules to support iron 
absorption by ensuring uptake in the small intestine (13,14). Due to the high prevalence of iron 
deficiency, infant formulas are generally highly fortified with electrolytic iron at levels up to 12 
to 13 mg/L, which is much higher than the recommended intake, but this strategy is likely 
necessary to counteract lower bioavailability of the iron source (15,16). As a general rule 
healthy, full-term infants that are exclusively breastfed do not require iron supplementation until 
approximately 6 months of age. Further, formula-fed infants should receive an iron fortified 
infant formula, and low birth weight or premature infants should receive iron supplementation 
along with fortified formula or human milk (17). After 6 months of age, all infants should ingest 
supplemental sources of iron-rich food, such as iron-fortified foods or naturally iron-rich foods. 
For infants 7 to 12 months of age, the recommended dietary allowance (RDA) increases to 11 
mg/d, and decreases to 7 mg/d for toddlers 1 to 3 years of age (18).  
For children and adults, the RDA ranges from 8 to 18 mg/d, varying by age and gender, 
and increasing to 27 mg/d for pregnant mothers (18). Specific RDA and iron requirement values 
for each age group and gender are summarized in Table 2.1. For children and adults, the best 
way to reach the recommended dietary intake is from consuming adequate amounts of iron from 
food sources known to be rich in the micronutrient. For pregnant women, the World Health 
Organization recommends oral elemental iron supplementation with ferrous sulfate, ferrous 
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fumarate, or ferrous gluconate in order to meet iron demands (19). Taken together, iron 
requirements and bioavailability of iron in food vary significantly between different age groups 
and food sources respectively. Thus, awareness of iron intake should be of high concern, 
especially in populations at risk for iron deficiency such as pregnant women and infants.  
Table 2.1. Dietary iron requirements by age  
(mg/d) 
 Recommended Dietary Allowance1 
 Gender 
Age Male Female 
0-6 months 0.27 0.27  
7-12 months 11  11  
1-3 years 7 7 
4-8 years 10 10 
9-13 years 8 8 
14-18 years 11 15 
19-50 years 8 18 
51+ years 8 8 
   
 Pregnancy Lactation 
14-18 years 27 10 
19-50 years 27 9 
1Values from the National Institutes of Health; 
intake value sufficient to meet iron requirements18 
 
Infant iron status at birth 
Due to rapid growth and development early in life, the infant has a high requirement for 
iron and is thus susceptible to iron deficiency. Potential risk factors of early life iron deficiency 
include: premature birth, low birth weight, gestational diabetes, smoking during pregnancy, and 
reduced iron stores in the mother (20,21). Further, research suggests that iron deficiency or IDA 
in the mother can increase the risk of premature birth or low birth weight, confounding the 
effects of iron deficiency in the neonate (22). One study found that IDA in a pregnant mother 
tripled the chances of having a low birth weight infant, and doubled the chances of premature 
birth (22).  
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The greatest quantities of iron stores are passed from the mother to infant throughout the 
third trimester, therefore premature infants are especially at risk for lower iron stores. For term 
infants, it is generally accepted that iron stores are sufficient to prevent anemia through 
approximately four to six months of age. However, amounts of lactoferrin naturally decrease 
from lactation onset to six months, thus lowering the bioavailability of iron utilizable to the 
infant over time. Taken together, despite the high bioavailability of iron in human milk, recent 
studies show term infants who are exclusively breastfed through six months of age are at risk for 
developing IDA. This is because iron in human milk, though highly bioavailable, is present in 
low concentrations (14,23). Thus, it is suggested that even full-term infants, especially those with 
other predisposing factors, begin iron supplementation at an earlier age to avoid iron deficiency 
(24). Importantly, even infants diagnosed with iron deficiency who do not present with IDA may 
have lasting detrimental effects on cognitive growth and development (4). Taken together, 
increased iron demands due to rapid growth of the infant, potentially low iron stores at birth, low 
iron concentration and/or bioavailability of food sources, and maternal iron status all contribute 
to the high prevalence of iron deficiency in the developing child, making it a major health 
concern.  
ID & IDA in infants 
Untreated iron deficiency in an infant can quickly progress to IDA. Symptoms of iron 
deficiency include faintness, excessive tiredness, and diminished cognitive function prior to 
clinical symptoms of IDA (3,9). As such, these same symptoms appear in IDA, however they 
can become more severe as the body becomes more deficient. It is widely accepted that adults 
with iron deficiency or IDA have fewer exercise sessions and decreased work performance 
(25,26). A study assessing cognitive function in children showed that iron deficiency with and 
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without anemia resulted in lower test scores compared with children that were iron sufficient 
(27). Specific to infants, a study assessing recognition memory at two months of age found that 
iron sufficient infants showed signs of recognizing their mother’s voice whereas infants with 
fetal-neonatal iron deficiency did not (28). These symptoms are even known to manifest before 
IDA is detectable by a decline in hemoglobin levels (3).  
As previously mentioned, iron deficiency and IDA have also been strongly linked with 
inflammation of the GIT, stemming from digestive diseases associated with cancers, ulcers, and 
celiac disease (3,5). Many other peripheral symptoms have been associated with iron deficiency 
such as atrophy of the lingual papillae on the tongue, leading to a glossy appearance, and angular 
stomatitis, or cracks at the corners of one’s mouth (29,30). Changes can also be seen in a 
patient’s nails as studies have found links between iron deficiency and the thinning of nails, 
causing them to be more brittle. Iron deficiency can also influence an individual’s eating habits, 
presenting as pica, or the tendency to eat non-nutritive substances such as dirt or paper (29). 
Further, it has been noted that patients with IDA sometimes have difficulty swallowing  
(dysphagia), though this symptom is not as widespread (30). It should also be noted that the latter 
mentioned symptoms are not as prevalent due to heightened awareness of iron deficiency and 
active supplementation of iron to prevent iron deficiency and IDA from an early age.  
Clinically, the most significant concern of IDA is its effects on RBC, where this 
condition reduces the size of RBC and decreases the amount of hemoglobin present in the body. 
It is widely accepted that severe IDA leads to increased skin paleness. This is due to a decreased 
amount of hemoglobin in each RBC causing a lack of color (hypochromia) (30). This is second 
to the earliest signs of IDA, which include anisocytosis and microcytosis, or inconsistency in 
RBC size and decreased RBC values, respectively (31). As some of the earlier-mentioned signs 
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are less prevalent and more difficult to categorize in infants, it is important to have defined 
markers of iron deficiency and IDA such as the alterations in RBC as well.  
Iron deficiency anemia has significant and lasting influences on the infant in regards to 
neural and cognitive development. It is known that iron plays a crucial role in neurodevelopment, 
including metabolic functioning, neurotransmission, proper myelination of the spinal cord, and 
development of white matter in the cerebellum (32–35). Moreover, iron plays a crucial role in 
enzymes involved in neurotransmitter synthesis, including tyrosine hydroxylase, which is 
responsible for synthesis of norepinephrine and dopamine (DA) (32). Iron is present in DA-
containing neurons throughout the brain and iron is known to affect DA metabolism as well as 
the density of DA receptors and transporters in specific brain regions (36). One such brain region 
is the striatum, which is integral for coordination of motor and action planning, decision-making, 
and motivation. Further, iron deficiency has been shown to increase blood vessel complexity in 
the cortex, thereby functionally influencing availability of nutrients required for 
neurodevelopmental processes (36). Studies have shown that maternal iron deficiency is related 
to poorer cognitive and neurodevelopmental outcomes in infants (33). Interestingly, infants 
exhibiting iron deficiency without anemia show altered cognitive development (37). Taken 
together, this evidence suggests that iron status during the fetal and neonatal period is critical for 
proper development, and iron deficiency could lead to changes in brain structure and function 
that could result in long-term alterations to behavior and cognition.  
Iron deficiency is also linked to alterations in the immune system, though many of these 
functions are not completely understood. Both clinical and preclinical studies have shown that in 
cases of iron deficiency or IDA, immune function is diminished and there is a higher 
susceptibility for infections (26). It should be noted, however, that most of these clinical studies 
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do not account for confounding issues such as poverty, malnutrition, and other micronutrient 
deficiencies. Despite the potential confounders, it is well-established that iron deficiency has an 
effect on immunity, specifically cellular immunity, which exhibits delayed development in cases 
of iron deficiency (38). Iron plays an essential role in immune function through the generation of 
peroxides and nitric oxide, which are necessary for normal functioning of immune cells, and 
through iron’s role in normal cell growth (26). Thus, in states of iron deficiency these normal 
physiological functions are inhibited and altered immune function develops. Studies have also 
shown that iron deficiency led to an increase in interleukin  (IL)-1  (IL-1) and IL-6, and a 
decrease in IL-2 and IL-10 (26,39). This finding may illuminate why chronic inflammation has 
been associated with iron deficiency, as IL-1 and IL-6 are pro-inflammatory cytokines and IL-2 
and IL-10 are anti-inflammatory (39).  
It should also be noted that many pathogenic bacteria require iron, meaning 
supplementation with iron may also increase susceptibility for infections. This occurs because 
the body is not able to sequester enough iron to prevent potentially harmful bacteria from 
acquiring the micronutrient and using it for cellular replication and processes, thus resulting in 
enteric diseases (40). It is also hypothesized that this phenomenon is a reason why iron in human 
milk tends to be present in a bound rather than a free form, thereby making it unavailable for 
potentially pathogenic bacteria and allowing a customary microbiota to colonize the developing 
GIT (13). Altogether, iron deficiency has been proven to affect many different functions 
including red blood cell production, neural and cognitive development, and immune 
development and functioning, some of which lead to long term alterations in the neonate.  
Iron metabolism  
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Iron is an essential micronutrient for many biological functions, making its absorption 
and utilization critical. However, in excess, iron can become toxic to the body. Therefore, 
regulation of iron uptake is pivotal to meet the demands of the body without allowing excess 
accumulation (26). The degree at which iron is utilized is highly dependent on the iron status of 
the individual, and in the case of iron deficiency, absorption greatly increases in the small 
intestine (SI), which is the first site of iron utilization and absorption in the body.  
The SI represents the main site for absorption of iron, with the majority of absorption 
occurring in the duodenum. Ferrous iron is considered more bioavailable due to its more efficient 
uptake in the SI where it is directly absorbed into the enterocyte by endocytosis (41). In contrast, 
ferric iron must be reduced to the ferrous form before absorption and utilization can occur. This 
process is carried out by ascorbic acid, or vitamin C, which is the most effective enhancer of iron 
absorption (8). It was also thought that duodenal cytochrome B  (DcytB), a ferric reductase 
located on the luminal membrane of enterocytes in the SI, aids in reducing ferric iron to the 
ferrous form, thus enhancing absorption of iron (42). However, emerging evidence suggests that 
DcytB may not play a role in iron absorption in humans as previously thought, as changes in 
expression of DcytB are not necessarily associated with variations in iron status (43,44). More 
evidence is needed to support this theory.  
Once reduced, the now ferrous iron is transported across the luminal membrane of the 
enterocyte by divalent metal transporter 1 (DMT1) (9). After absorption into the enterocyte, both 
heme and non-heme iron follow the same path, as they are freed by the action of heme 
oxygenase (HO-1) (45). For non-heme iron, this typically occurs after conversion back to its 
ferric state. Because the main site of absorption for iron is in the duodenum, HO-1 naturally has 
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greater expression and activity in the upper SI. Further, during iron deficiency, HO-1 increases in 
activity, presumably to prevent an ID state and counteract the onset of IDA (46).  
Absorption of iron through the basolateral membrane of enterocytes occurs via active 
transport, which is mediated by ferroportin (Fpn) in association with hephaestin (Hp). 
Ferroportin is the controlling factor in permitting iron to pass into circulation from the mucosal 
cells (47). Hephaestin is a transmembrane, copper-dependent ferroxidase that catalyzes oxidation 
of ferrous iron back to the ferric form, promoting its release and binding to circulating 
apotransferrin (i.e., transferrin without a bound iron group) (39).  
This pathway is highly defined in the fully developed GIT. However, in the infant uptake 
and control of iron absorption is less understood, as the iron uptake regulatory mechanisms are 
not yet fully developed (48). Infant studies have shown that the intake of iron does not correlate 
with iron status, with iron supplementation between 4 and 6 months of age correlating with 
increased Hb concentration regardless of initial iron status (49). It is thought that regulation of 
iron absorption in infants is mature by approximately 9 months of age, at which point the uptake 
of iron is more tightly regulated based on iron status (44). Accordingly, iron absorption in infants 
is enhanced by the presence of lactoferrin. Lactoferrin, a glycoprotein naturally found in human 
milk, is capable of binding 2 ferric iron molecules, and heightens iron absorption in the infant by 
ensuring uptake in the SI (13,14). It is absorbed directly across the luminal membrane of 
enterocytes via a lactoferrin receptor, and internalized along with its bound iron (44).  
After iron is absorbed and enters the intracellular iron pool, its use is still tightly 
regulated. Due to the reactive nature of iron, it is bound by carrier proteins, ferritin or transferrin, 
for either storage or transport via circulation, respectively, to avoid oxidative stress. More 
specifically, ferritin binds to iron that is storage-bound, and is mainly conserved as cytosolic 
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ferritin in the liver (47), though it can also be stored in bone marrow and, to a lesser extent in the 
spleen and muscles (50). Transferrin binds iron that stays in circulation and delivers it to tissues 
throughout the body by binding to transferrin receptors located on cell surfaces, resulting in 
uptake of iron in cells as needed (47). The main inhibitors in the process of iron absorption 
include phytate, found in cereal products, and polyphenols, found in plant products, which bind 
iron and contribute to reduced bioavailability (8). However, the pro-absorptive action of dietary 
ascorbic acid has been found to significantly counteract the inhibitory effect of phytate and 
polyphenols on iron absorption (8,51). 
Microbial iron metabolism and the infant microbiota 
The microbiota is the collection of all bacteria on and in our bodies. The microbiome is 
the collection of all genetic material associated with the microbiota. The gut microbiota has been 
of heightened focus in recent years as its importance is increasingly being understood. We now 
have more insight into the mechanisms through which the gut is colonized, how the host can 
influence or alter the microbiota, and how the microbiome influences the host. In doing so, it has 
been found that early colonization of the infant GIT can have long lasting effects on the future 
health of the child (52). Iron not absorbed by the SI for use throughout the rest of the body 
continues through the GIT to the large intestine (LI). The fermentative environment of the LI 
supports extremely high levels of bacterial growth, and thus allows for bacterial utilization of 
macro- and micro-nutrients not absorbed by the host. As such, iron that reaches the LI is largely 
utilized by certain strains of bacteria. It is commonly accepted that microbes such as 
lactobacillus do not require iron, whereas potentially pathogenic microbes such as C. difficile, E. 
coli, and B. cereus thrive in iron-rich environments (53). Consequently, the amount of iron that 
reaches the LI has a direct effect on the gut microbiota. Iron-requiring bacteria scavenge the LI 
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for free iron, or utilize iron found in free hemoglobin (54). The process of utilizing free iron 
particles is mediated by receptors on the microbes’ cell surface, which binds iron for uptake into 
the cell. Excess absorption of iron may become toxic to microbes, thus uptake of bioavailable 
iron is highly controlled by ferric uptake regulator or Fur (54). The absorbed iron is then stored 
in microbes and conserved in high-iron environments, or utilized by microbes in iron-deficient 
environments.  
The infant has a GIT that is commonly reported as sterile until birth, though emerging 
evidence show that some infants may acquire bacterial species from the mother in utero (55–57). 
The makeup of the microbial community is found to be dependent on many factors. The mode of 
delivery plays a significant role in the makeup of the neonatal microflora and is dependent on 
whether the infant was derived vaginally or via cesarean section (C-section) (58). Infants derived 
vaginally are inoculated by maternal fecal and vaginal bacteria, whereas infants derived via C-
section are colonized through bacteria from the skin, hospital environment, and medical staff, 
thus greatly altering the type of microbes to which the infant is initially exposed (59). Studies 
have shown that infants born via C-section have significantly lower microbial diversity than 
those that are vaginally derived due to lost exposure to maternal microbes (52). Other factors that 
play into the diversity of the newly developed neonatal microbiota include use of antibiotics, 
breastfeeding versus formula feeding (58), environment, caregivers (55), and even genetics (60).  
As mentioned above, the microbiome has been found to exert physiological influences on 
the host. The microbiome plays a key role in health as it helps with vitamin K production, aids in 
certain metabolic functions such as fiber fermentation, formation of short chain fatty acids  
(SCFA) and utilization of unused SCFA from the host, provides a barrier for colonization of 
pathogens, and stimulates development of the neonatal immune system (59). Further, evidence 
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suggests the gut microbiota influences development of allergies, in addition to GIT development 
(61,62). 
Though much is known about the healthy adult human microbiota throughout the entire 
GIT, less can be said for the infant. Due to the sensitive nature of the infant, information on the 
microbial makeup of the stomach, SI, and LI are sparse. The fecal microbiota of the infant has 
been more extensively studied and used to make assumptions as to the microbial composition of 
the intestinal tract (55). As stated previously, the mode of delivery can greatly affect the initial 
makeup of the neonate’s microbiota. Studies on the microbiota of healthy, term infants derived 
either vaginally or via C-section showed dominance in the phylum Actinobacteria  (with main 
representation from the genus Bifidobacterium), as well as Firmicutes, Proteobacteria, and 
Bacteroidetes (52,63). Infants who were derived via C-section showed significantly lower 
amounts of Escherichia-Shigella  (phylum Proteobacteria) and displayed an absence of microbes 
in the Bacteroidetes phylum, though this phylum was found in half of the infants on study (52). 
This was concurrent across feeding practices, either breastfed or formula fed, though differences 
in microbiota composition were also shown to vary pending method of feeding. Formula-fed 
infants were found to have higher incidence of C. difficile, a potentially pathogenic bacteria often 
linked to enteric diseases, and other members of the families Peptostreptococcaceae and 
Verrucomicrobiaceae regardless of mode of delivery (52). These findings are consistent with 
other infant microbiota studies, though some observed a prevalence of C. difficile, and relative 
abundance of Bifidobacterium due to mode of delivery as well (59,61). As such, many factors 
affect the infant microbiome, which is highly dynamic early in life, and contributes to the high 
variability seen in the gut microbiota between infants during the first year of life, with increased 
variability during the first few months (63,64).  
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The microbiota is thought to stabilize and become more ‘adult-like’ after one year of age 
(56,65). Overall, consistent findings across multiple studies indicate that formula-fed infants 
showed greater richness and diversity compared to breastfed infants (52,62), and infants derived 
via C-section showed the lowest diversity (52). The increased degree of richness and diversity 
noted in formula-fed infants as opposed to breastfed infants potentially has links to the role of 
human milk oligosaccharides (HMO). One in vitro study found that HMO derived from human 
milk supported growth of the Bifidobacterium species, serving as a metabolic substrate mainly 
for that strain of gut microbes as opposed to others (66). This hypothesis is backed by in vivo 
studies that concluded that HMO influence the microbial composition in the infant. Specifically, 
the amount of HMO consumed can be a factor used to predict relative abundances of certain 
microbes that utilize HMO as a metabolic substrate such as those in the Bifidobacterium and 
Bacteroides species (62). 
The microbiota is a balanced community that is now known to be heavily influenced by 
diet (67). Mounting evidence shows that iron status itself can have a great impact on the 
microbial population, though most studies correlating the effects of iron status on the gut 
microbiota focus on iron supplementation. Such studies looking into the effects of iron 
supplementation on the microbiota, performed both in vitro and in vivo, and both clinical and 
pre-clinical, conclude similar findings. Excess iron unabsorbed by the host and reaching the 
colon leads to negative side effects due to alterations in the microbial community and its 
interactions with the host (67). Studies show that increased iron supplementation or available 
iron leads to an increase in potentially pathogenic, iron-requiring bacteria (e.g., E. Coli, C. 
difficile, and Bacillus cereus) and a decrease in bacterial species thought to promote health (e.g., 
Bifidobacterium and Lactobacilli) (68–70). Iron supplementation also increased the incidence of 
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diarrhea and fecal calprotectin, an intestinal inflammatory marker (53). Few studies have noted 
effects of iron deficiency on the microbiota. Of those studies, most were conducted in vitro, or in 
vivo but performed in the rodent model. Iron-deficient rats exhibited increased abundances of 
Lactobacilli (phylum Firmicutes) and Enterobacteriaceae (phylum Proteobacteria), along with 
decreases in the concentration of Bacteroides (phylum Bacteroidetes). Once provided an iron-
replete diet, the concentrations of these bacteria returned to near-baseline (71). These findings 
were corroborated by other studies, which found iron deficiency decreased microbial diversity 
both within (alpha diversity) and between (beta diversity) bacterial communities, and dietary iron 
repletion, though showing some improvement, was not able to match microbial composition of 
iron-adequate groups (72). The decrease in Bacteroides is, however, controversial, as this 
phenomenon was not consistent across studies. It is thought that the method of quantifying 
Bacteroides may have been biased in identifying closely-related species in studies noting a drop 
in the genus, instead of Bacteroides specifically (72). Overall, it has been consistently found that 
iron status, specifically iron deficiency, can significantly alter the gut microbiota’s composition, 
leading to decreased diversity that is only partially recovered with iron repletion (71). Due to the 
limited data, future studies are needed to validate the alterations iron deficiency has on the 
neonatal gut microbiota.  
Iron in the brain 
Iron plays an essential role in the development and function of many neurological 
pathways, thus, iron must be available and capable of transport into the brain. Though highly 
important, the process and regulation of iron accumulation in the brain and the mechanisms used 
to deliver iron to various brain regions is still poorly understood. The brain requires iron for 
proper development and functioning, but the sensitive nature of the brain leaves it vulnerable to 
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oxidative damage in cases of iron overload (73). Taken together, the process of iron uptake into 
the brain and its transport to cells within the brain is tightly regulated (73). As cells of the brain 
do not have direct access to the plasma iron pool due to the blood brain barrier, increased 
regulation of iron entering the brain is necessary, and other methods must be used for the brain to 
acquire iron (74).  
The process of acquiring iron from the plasma pool into the cerebrospinal fluid  (CSF) is 
mainly controlled by the blood brain barrier, with the choroid plexus playing a part in regulation 
of iron movement as well (32). The transfer of iron across the blood brain barrier is carried out 
by the iron transport protein, transferrin (73). This occurs via the transferrin receptor  (TR), a 
transmembrane glycoprotein that is present in all iron-requiring cells, and controls cellular 
uptake of transferrin-bound iron mostly by receptor-mediated endocytosis (75). Transferrin 
receptors are present on the choroid plexus epithelial cells, brain capillary endothelial cells, and 
neurons, thus regulating the entry of transferrin-bound iron across the blood brain barrier and 
into the CSF (75). Both iron status and developmental stage have an effect on the expression of 
TR, with iron deficiency increasing TR located along the blood brain barrier to allow increased 
entry of iron into the brain, and iron sufficiency decreasing entry of iron into the brain (32). 
DMT1 is also known to play a role in brain iron transport, though some aspects of its function 
are yet to be understood. However, Zywicke and colleagues found that DMT1-deficient rats 
showed decreased iron concentrations in the brain, suggesting the transporter plays a role in iron 
movement once it has crossed the blood brain barrier (76). Once endocytosis of the transferrin 
receptor-iron complex occurs and iron is released into the endosome, it is speculated that DMT1, 
located within endothelial cells and on astrocytes, then transports iron to the cellular cytoplasm 
(74,76). 
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Once inside the brain, it is clear that iron demands vary between developmental state and 
between brain regions. The concentration of iron in the brain is highest at birth and steadily 
decreases through weaning, but is increased again at the onset of myelination (32). Regionally, 
the basal ganglia, deep cerebellar nuclei, caudate nucleus, putamen, globus pallidus, and 
substantia nigra have been found to be extremely rich in iron, the latter of which does not peak 
until adolescence (32). Thus, it is clear that regional regulation of iron uptake within the brain is 
required. This is thought to be controlled by TR on the blood brain barrier endothelial cells along 
with feedback from the specific regions themselves (74). Further, the choroid plexus contains 
transferrin mRNA, and secretes the transferrin protein into the ventricles of the brain, which is 
speculated to be a mode of delivery of iron to other regions of the brain (74). However the 
mechanisms of this process remain poorly understood. 
As previously mentioned, iron plays a role in the brain in a wide variety of biological 
functions, as well as playing a crucial role in many enzymatic activities. One of the most basic 
and imperative roles of iron in the brain, as well as the rest of the body, is its involvement in 
adenosine triphosphate (ATP) and deoxyribonucleic acid (DNA) synthesis, as iron is used as a 
cofactor in both of these processes (74). More specifically, succinate dehydrogenase and 
aconitase are enzymes in the Krebs cycle  (involved in ATP synthesis) that are dependent on 
iron, along with ribonucleoside reductase, which is a rate-limiting enzyme in DNA synthesis 
(42). The brain has high ATP demands, as it is required for many active processes such as 
maintaining ionic gradients and being used in synaptic transmission and axonal transport (42). 
The brain has additional iron demands for processes such as neurotransmission, 
myelination, dendritogenesis, and synaptogenesis development and functioning, which are also 
dependent on the use of enzymes and hemoproteins that contain iron (77). These processes are 
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regionally affected depending on the time of onset of iron deficiency and the specific regions 
along the developmental timeline (77). As iron deficiency is known to be predominant in later 
infancy and early toddlerhood, corresponding with the period during which myelination, 
dendritogenesis, and synaptogenesis are peaking, effects can be severe (35). 
It is widely accepted that iron plays a crucial role in neurotransmission, acting as a 
cofactor for tryptophan hydroxylase and tyrosine hydroxylase, both of which are involved in the 
synthesis of neurotransmitters, and the latter specifically of norepinephrine and DA (42). Studies 
have also shown effects on serotonin and norepinephrine transporter densities in response to iron 
deficiency (35). Iron deficiency is also known to lead to hypomyelination (7). If the timing of 
iron deficiency corresponds with periods of myelination (78), then iron status may have profound 
effects on the developing myelin sheaths. Further, lipids and cholesterol, both of which require 
iron for biosynthesis, play a role in both the synthesis and metabolism of myelin (42). 
Regionally, iron deficiency has been shown to have significant impacts on the developing 
hippocampus (spatial learning and memory) (79) and striatum  (motor and reward systems) (80). 
The cumulative effects of iron deficiency on the various biological functions in the brain lead to 
alterations in these regions, and, in turn, cause long term cognitive delays and alterations in 
motor skills. Iron not utilized immediately for the aforementioned biological functions in the 
brain is stored as ferritin for later use. Collectively, iron transport into and throughout the brain is 
an important and tightly-regulated process as it plays a significant role in the development of the 
neonatal brain and brain functioning of many neurological pathways throughout life.  
Iron in the periphery 
Iron is known to play many roles in the body, making up four major classes of proteins. 
This includes non-enzymatic hemoproteins (hemoglobin, myoglobin, and cytochromes), heme-
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containing enzymes, iron-sulfur enzymes, and lastly enzymes that are non-sulfur and non-heme 
containing (26). In cases of tissue iron deficiency, the activity of many of these enzymes is 
decreased (26). Accordingly, iron plays a major role in oxygen transport throughout the body and 
acts as a key component or cofactor in many biological processes such as DNA synthesis and 
energy production. Iron not being utilized in these processes is mainly stored in the liver as 
ferritin for later use (26). 
In the term infant, approximately 75-80% of iron is incorporated into RBC as hemoglobin 
to transport oxygen in circulation, 10% in tissue proteins  (myoglobin and cytochrome), involved 
in oxygen delivery in muscle and involvement in energy metabolism as an electron transfer agent 
respectively, and 10-15% going to storage (20). A vast majority of the iron required for 
erythropoiesis is derived from old RBC which are recycled by macrophages (81). If this is 
inadequate to meet iron demands for erythropoiesis, then iron stored in the liver is released for 
use. Hemoproteins can also be utilized in enzymes such as oxygenases, peroxidases, nitric oxide 
synthases, and guanylate cyclase (82). Heme-containing enzymes are typically coupled with 
other enzymes, such as the cytochrome P450 complexes, to act as a cofactor and are also utilized 
in the electron transfer process (26). This complex is present in many tissues, but primarily 
located and most abundantly found in the liver (9). Iron-sulfur enzymes are those involved in 
ATP synthesis, as well as acting as a cofactor for succinate dehydrogenase and aconitase, 
enzymes involved in the Krebs cycle (42). Lastly, non-sulfur, non-heme-containing enzymes  are 
those not incorporated into a porphyrin ring structure, and are also not part of an iron-sulfur 
complex; an example includes those enzymes involved in processes such as DNA synthesis (42). 
Taken together, iron plays a significant role in the periphery through involvement in several 
imperative biological functions.  
 21 
 
Numerous clinical indicators can be used to evaluate iron status. Many of these 
biomarkers are in circulation with the most common being red blood cell characteristics such as 
hematocrit (Hct) and hemoglobin (Hb) levels, which indicate functional iron in the body (83). 
Testing these parameters is easily conducted and economical, and it is well established that Hct 
and Hb concentrations decrease in cases of iron deficiency (84). Reference ranges for the human 
infant and young pig can be found in Table 2.2. However, these are among the least responsive 
or slowest indicators of low iron status, meaning other methods of diagnosis are critical for early 
detection. Biochemical tests can be utilized to detect iron deficiency earlier by quantifying serum 
ferritin, transferrin saturation, and erythrocyte protoporphyrin concentration (85). In cases of iron 
deficiency, serum ferritin and transferrin saturation are decreased, while erythrocyte 
protoporphyrin concentration increases (3,84). 
 
 
Changes in serum ferritin manifest prior to alterations in Hct and Hb, and levels of serum 
ferritin directly correlate to the amount of iron stores available in the body. This makes serum 
ferritin an optimal test for earlier detection of iron deficiency. Serum ferritin can be measured by 
various techniques including radioimmunoassay, immunoradiometric assay, and enzyme-linked 
immunosorbent assay (ELISA) (86,87). However, because serum ferritin is an acute-phase 
reactant, diseases such as cirrhosis, arthritis, hepatitis, inflammation, or chronic infection can 
affect serum ferritin concentration by showing normal-to-elevated levels even in the presence of 
Table 2.2.  Hematological reference ranges for the human infant and young pig1 
 Infant  Young Pig 
Hematology Normal Anemic  Normal Anemic 
Hematocrit, %PCV 47-65% < 45%  32-50% < 30% 
Hemoglobin, g/dL 13.5 -17.5 g/dL < 12 g/dL  9-10 g/dL < 7 g/dL 
1Values displayed represent levels expected at approximately one week of age.  
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iron deficiency (3,88). Transferrin saturation, a measure that indicates the amount of iron being 
transported by transferrin, can also be calculated to determine if a subject is experiencing iron 
deficiency. Transferrin saturation is calculated by dividing the concentration of serum iron by 
total iron binding capacity (TIBC; the amount of available sites on transferrin for iron to bind) 
and multiplying by 100 to express the value as a percent (89). This measure is not as easily 
available for screening of iron deficiency as no clinical methods have been established or 
validated. Transferrin saturation is also highly variable, as serum iron concentration can be 
affected by diurnal cycle, meals, inflammation, and infection (88). Further, TIBC is less sensitive 
to iron status than serum ferritin, with decreases in TIBC occurring after iron stores have already 
been depleted (88). Erythrocyte protoporphyrin has established clinical methods for 
measurement and is similarly an earlier indicator of iron deficiency than Hct and Hb, however, it 
is also elevated by infection and inflammation, as well as in cases of lead poisoning (90). 
A newly established indicator of iron status is hepcidin concentration. Hepcidin, 
synthesized in the liver, has been found to regulate iron stores in the body as well as in serum by 
binding to ferroportin, effectively regulating the transport of iron out of enterocytes (91). An 
increased hepcidin concentration correlates with iron sufficiency, while a decreased 
concentration correlates with iron deficiency, though inflammation can lead to increased 
concentrations (16). No clinical methods have been established for determining hepcidin 
concentration, but laboratory methods such as ELISA can be utilized (91).  
It is important to note that most focus has been placed on defining sensitive clinical 
biomarkers for IDA, but not iron deficiency, which can also have consequences on the 
developing neonate. Thus, earlier detection of iron deficiency is optimal to prevent manifestation 
of symptoms associated with iron deficiency and IDA. The previously mentioned biomarkers are 
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indicative of iron status though, and levels signifying IDA have been well defined in the infant. 
Given that there are many methods of clinically diagnosing iron deficiency, as well as each test 
showing significant strengths and limitations, establishing iron deficiency is best determined by 
using a combination of indicators. 
Reversibility of iron deficiency/IDA 
Most symptoms associated with iron deficiency are found to be reversible with iron 
supplementation depending on the severity of deficiency and timing of repletion. Iron, as a main 
component of RBC, has a significant influence on blood parameters. Alterations in RBC 
parameters are among the last symptoms to show up in cases of iron deficiency, and the first to 
recover. In general, iron stores fully recover with an adequate amount and length of iron 
repletion in the diet (92). Iron also plays a critical role in the development of the neonatal brain. 
Iron deficiency and IDA during infancy can severely alter this process, resulting in changes in 
brain physiology and function which lead to long-lasting alterations in behavior and cognition. 
The severity and timing of iron deficiency may affect the extent of these alterations, but it is 
known that infants with iron deficiency or severe IDA have delays such as poorer motor, social-
emotional, and cognitive functions that lead to long-term, irreversible consequences which 
present later in life (35,37). As stated above, iron deficiency also has a significant effect on the 
developing microbiota by severely decreasing alpha and beta diversity of the microflora, which 
is only partially recovered with iron repletion (71). Overall, with iron repletion, blood parameters 
and iron storage levels are restored, however, pending the timing and severity of the deficiency, 
alterations in cognition and the microbiome may not fully recover.  
Utilizing the young pig as a biomedical model 
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To date, most research in animal models involving early-life iron deficiency has been 
conducted in rodent models. Mounting evidence suggests that the young pig is a more 
appropriate model for direct translation of findings to human infants due to strong similarities 
between the two species. This includes similarity in brain development, physiology and 
cognition, as well as the microbiota-gut-brain axis (1,93). Moreover, the young pig is becoming 
an increasingly popular model when assessing the effects of specific dietary compounds on 
neurodevelopment. This is due to similar brain and gastrointestinal tract structure, as well as 
growth trajectories with one month of brain growth in the infant being equivalent to one week of 
brain growth in the young pig (94).  
The porcine model has already been validated as superior when evaluating normal brain 
development of humans, and has been proven to have marked similarities to the human infant. 
Some resemblances include similar proportions of gray and white matter, patterns of 
development and myelination, and timing of perinatal brain growth spurts, along with both 
species having gyrencephalic brains (95). Further, both the human infant and the young pig are 
known to have similarities in gut structure. Morphologically, the two have comparable digestive 
tracts with only minor deviations in the young pig, none of which are considered to make a 
significant difference in the digestive process when compared to the neonate. Similar findings 
have been noted in the microbiota between the two. No significant differences between the 
microbial compositions of the human infant and young pig were observed. While some dominant 
strains of bacteria do differ locally throughout the GIT between humans and pigs, this is not 
thought to be of major significance nutritionally (55). 
As already established, iron deficiency is one of the leading micronutrient deficiencies in 
humans that greatly affects development during the neonatal period. The same is true for young 
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pigs for many reasons that parallel those seen in the human infant, including low levels of iron 
stores at birth, increased iron demand due to heightened growth trajectories after birth, low iron 
availability in porcine milk, and immature absorption kinetics until later in life (89). Overall, 
young pigs show parallels to human infants in terms of brain structure, gut morphology, 
metabolism, immunology, and iron status at birth, making them an excellent model for an iron 
deficiency study (96).  
Conclusion 
Iron deficiency has proven to be a major health concern throughout the world, 
specifically in the infant population, which is at greater risk due to heighted iron demands. As 
iron is involved in many biological processes, a deficiency at a critical time can lead to lasting 
effects in cognitive development and alterations in the gut microbiota. Even with iron repletion, 
some impairments can be irreversible. As iron stores in the central nervous system are decreased 
before hematological expression is impacted, impacts on cognition can manifest before IDA is 
diagnosed. For that reason, it is imperative that early detection and defined values of iron 
deficiency itself are developed. The young pig model is ideal for studying the effects of iron 
deficiency and IDA preclinically due to many biological similarities between the infant and the 
young pig. Due to the significant impacts iron deficiency and IDA have on the developing 
neonate, the aim of this study is to utilize the young pig model in a longitudinal experiment to 
determine effects of IDA on peripheral and cognitive outcomes, as well as effects on the 
microbiota. Further, to establish the critical window in which iron repletion may be able to 
compensate for early life IDA. 
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CHAPTER 3: LONGITUDINAL EFFECTS OF IRON DEFICIENCY ANEMIA AND 
SUBSEQUENT REPLETION ON BLOOD PARAMETERS AND THE RATE AND 
COMPOSITION OF GROWTH IN PIGS 
3.1 ABSTRACT 
Iron deficiency is reported as the most common nutrient deficiency worldwide. Due to 
rapid growth, infants are at particular risk for developing iron deficiency, which can easily 
progress to iron deficiency anemia if not treated. The aim of this study was to determine the 
lasting effects of an early-life iron deficiency after a period of dietary iron repletion. Forty-two 
intact male pigs were ad libitum fed either control (CONT, 21.3 mg Fe/L) or iron-deficient (ID 
2.72 mg Fe/L) milk replacer from postnatal day (PND) 2 to 32 (phase 1). From PND 33 to 61 
(phase 2), all pigs were transitioned through a series of industry-standard, iron-adequate diets. 
Blood was collected weekly from PND 7 to 28, and again on PND 35 and 56, and tissues were 
collected at either PND 32 or PND 61. At the end of phase 1, ID pigs exhibited reduced hematocrit 
(P < 0.0001) and hemoglobin (P < 0.0001) compared with CONT pigs, but neither hematocrit (P 
= 0.5968) nor hemoglobin (P = 0.6291) differed between treatment groups after dietary iron 
repletion at the end of phase 2. Body weight gain was reduced (P < 0.0001) 58% at PND 32 in 
ID pigs compared with CONT pigs during phase 1, and this effect remained significant at the end 
of phase 2 (P = 0.0001) with ID pigs weighing 34% less than CONT pigs at PND 61. Analysis 
of peripheral protein and mRNA gene expression biomarkers yielded inconclusive results as 
would be expected based on previous biomarker analyses across multiple species. These findings 
suggest that early-life iron status negatively influences blood parameters and growth 
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performance, with dietary iron repletion allowing for full recovery of hematological outcomes, 
but not growth performance.  
 
3.2 INTRODUCTION 
Early-life nutrition profoundly influences the developing neonate, with some effects that 
are long-lasting and irreversible, as is the case for iron. Iron is an essential micronutrient for 
many biological processes, yet iron deficiency is considered the most prevalent micronutrient 
deficiency worldwide (1). Though iron deficiency affects individuals of all age groups, women 
of childbearing age and children from birth to five years of age are at increased risk for 
developing iron deficiency (2). Further, infants, specifically, are at increased risk due to 
heightened growth trajectories early in life. Taken together, the effects of iron deficiency on the 
infant can be severe, especially if iron deficiency is left untreated and progresses to iron 
deficiency anemia (IDA). The extent of detrimental outcomes in response to iron deficiency are 
dependent on the timing and severity of deficiency experienced (3,4). Clinically, the most 
significant impact of IDA are effects on red blood cells, though this is known to recover quickly 
with dietary iron repletion. If severe enough, IDA has also been shown to affect growth in young 
children (5).  
The current study utilized the young pig as a model for the human infant. The pig has 
been successfully used as a pre-clinical model for iron deficiency due to its marked similarities 
in physiological responses to this particular micronutrient deficiency (6–9). Specifically, the 
young pig parallels the human infant in having low iron stores at birth, low availability of iron in 
porcine milk, immature iron absorption pathways in early life (10), and heightened growth 
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trajectories after birth (11). Further, pigs have similar physiology and nutrient requirements as 
human infants (12), but with relatively accelerated growth rates, making them an optimal model 
for early-life nutrition research. Taken together, the porcine model proves to be a powerful 
translational model for studying the influence of early-life nutrition on physiological and 
developmental systems (13).  
This study sought to characterize the effects of early-life IDA, before and after dietary 
iron repletion, on outcomes involving growth, body composition, hematology, and metabolism. 
Further, we aimed to establish whether reversibility with dietary iron repletion could compensate 
for effects resulting from early-life iron deficiency.   
3.3 MATERIALS AND METHODS 
Animal Care and Use 
All animal and experimental procedures were in accordance with the National Research 
Council Guide for the Care and Use of Laboratory Animals and approved by the University of 
Illinois at Urbana-Champaign Institutional Animal Care and Use Committee. Forty-two naturally-
farrowed, intact male pigs were obtained from a commercial swine farm in one of two replicates 
and transferred to the University of Illinois Piglet Nutrition and Cognition Laboratory (PNCL) at 
PND 2. Per standard agricultural protocol, pigs were provided an intramuscular injection of a 
prophylactic antibiotic (0.1 mL of ceftiofur crystalline free acid as Excede, Zoetis, Parsippany, NJ) 
within 24 h of birth. Contrary to typical agricultural procedures, pigs on this study were never 
provided supplemental iron (i.e., injectable iron dextran), because iron is the nutrient of interest. 
Recent pig studies observed hippocampal transcriptome changes (14) and possible effects of iron 
overload (7) after iron dextran administration in the first few days of life, which further justify our 
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decision to not provide iron dextran to any pigs. Upon arrival to PNCL on PND 2, pigs were 
randomized to one of two experimental diets, described below. Pigs were provided experimental 
milk replacer treatments from PND 2 until PND 32 or 33 (phase 1), at which point both treatment 
groups were transitioned through a series of industry-standard diets from PND 32 or 33 until PND 
61 or 62 (phase 2).  
For phase 1 of this study, 42 piglets were housed individually in custom pig rearing units 
(87.6 cm long, 88.9 cm wide, 50.8 cm high), which were composed of three acrylic walls, one 
stainless steel wall, and vinyl-coated, expanded-metal flooring. This caging environment was 
designed for pigs to see, hear, and smell, but not touch, neighboring pigs. Pigs were allowed to 
physically interact with one another for approximately 15 minutes each day, and each pig was 
provided a toy for enrichment in their home-cage throughout the study. Facility lighting was 
maintained on a 12 h light and dark cycle from 0800 to 2000 hours, with ambient temperature set 
at 26.6°C for the first 21 days of the study and gradually lowered to 22°C during the last seven 
days of phase 1.  
For phase 2 of this study, 20 pigs (n = 10 per diet) from phase 1 were transferred to the 
University of Illinois Veterinary Medicine Research Farm at PND 32 or 33 until the end of the 
study. While in this facility, pigs were housed individually in floor pens (1.5 m2) and the rearing 
environment was maintained on a 12 h light and dark cycle from 0800 to 2000, with ambient 
temperature set at 22°C.  
Dietary Treatments 
For phase 1 of this study, pigs (n = 21 per diet) were provided one of two milk replacer 
treatments with varying iron content. The control diet (CONT) was formulated to meet all of the 
nutrient requirements of the growing pig and was formulated to contain 106.3 mg Fe/kg milk 
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replacer powder. The iron deficient (ID) diet was identical to the CONT diet, with the exception 
that ferrous sulfate (i.e., the predominant iron source in CONT) was removed to provide only 13.6 
mg Fe/kg milk replacer powder. Additionally, both diets were formulated to contain ARA and 
DHA at 2.08 g and 1.04 g/kg milk replacer powder, respectively. Milk replacer was reconstituted 
fresh daily with 200 g of milk replacer powder per 800 g water. Thus, formulated iron 
concentrations in reconstituted pig milk replacers were 21.3 and 2.72 mg Fe/L milk replacer for 
the CONT and ID treatments, respectively. All pigs were provided ad libitum access to liquid milk 
replacer treatments from PND 2 until PND 32 or 33.  
For phase 2 of this study, all pigs (n = 10 per diet) were transitioned through a common 
series of industry-relevant, iron-adequate diets (containing 180-300 mg Fe/kg of diet), regardless 
of their phase 1 dietary iron treatment group. Pigs were provided ad libitum access to standard 
complex diets (major ingredients including corn, whey, and soybean meal) and standard 
agricultural feeding practices were followed by sequentially switching to stage 1, 2, and 3 diets on 
PND 32, 41, and 50, respectively. During phase 2 of the study, all diets were formulated to meet 
all nutrient requirements of growing pigs (15), including iron. No zinc oxide, copper sulfate, or in-
feed antibiotics were included in any diets. Analyzed values of iron in diets can be found in Figure 
3.1.  
Porcine milk was collected as part of a previous study (16). Samples were then analyzed 
for mineral profiles by using standardized procedures (Mead Johnson Nutrition, Evansville, IN) to 
establish iron content. Specifically, porcine milk samples were digested using a combination of 
concentrated nitric acid and 30% hydrogen peroxide at 220°C for 10 minutes in a microwave 
digestion system (UltraWAVE; Milestone Inc., Shelton, CT). After digestion, the samples were 
diluted to volume and quantified by inductively-coupled plasma mass spectrometry (ICP-MS; 
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NexION 300D; Perkin Elmer, Waltham, MA). The instrument was operated in kinetic energy 
discrimination mode using helium to reduce polyatomic interferences. All samples were analyzed 
in duplicate. 
Growth Performance 
Individual body weights and milk hopper weights were recorded daily utilizing a custom-
built scale (ShapeMaster Inc., Ogden, IL) to assess growth performance during phase 1. During 
phase 2, body weights were recorded weekly utilizing a large animal scale (Osborne Industries, 
Osborne, KS), and net disappearance of feed was recorded daily by weighing back each feeder on 
a validated digital scale (Pelouze Scale Corp, Oak Brook, IL). 
Hematological Outcomes 
Approximately 100 µl of blood was collected from the ear of each pig on PND 7, 14, 21, 
28, 35, and 56. All samples were immediately subjected to testing using a clinical blood analyzer 
(i-STAT; Abbott Point of Care, Princeton, NJ) utilizing i-STAT Chem8+ cartridges (Abbott Point 
of Care, Princeton, NJ). The clinical equipment passed all internal calibration and quality 
assurance checks prior to analysis at each sampling time-point.   
Blood and Tissue Collection, Processing, and Analysis 
At PND 32 and 33 (CONT, n = 6; ID, n = 7) and PND 61 and 62 (N = 20; n = 10 per phase 1 
diet), pigs were euthanized for tissue and blood collection. All animals were euthanized in a food-
deprived state, with no access to dietary treatments for at least 6 hours prior to euthanasia. Pigs 
were anesthetized using an intramuscular injection of telazol:ketamine:xylazine administered at 
0.022 mL/kg bodyweight (50.0 mg tiletamine plus 50.0 mg of zolazepam reconstituted with 2.50 
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mL ketamine (100 g/L) and 2.50 mL xylazine (100 g/L); Fort Dodge Animal Health, Overland 
Park, KS). To ensure pigs were properly anesthetized prior to euthanasia, all pigs were tested for 
reflex via the eye blink response. Pigs were euthanized using a 390 mg/mL sodium pentobarbital 
solution (Patterson Veterinary Supply, Columbus, OH) at 1 mL/5 kg body weight by intracardiac 
injection. Blood was collected from the jugular vein immediately after euthanasia on PND 32 and 
61, and collected into evacuated serum and EDTA-containing tubes (BD, Franklin Lakes, NJ). 
Serum was left at room temperature to clot for at least thirty minutes. Plasma was collected into 
EDTA tubes, gently inverted and stored on ice for up to four hours until processing. Serum and 
plasma were processed by spinning blood down utilizing an Allegra 6R centrifuge (Beckman 
Coulter Life Sciences, Indianapolis, IN), aliquoted, and stored at -80°C. Serum was analyzed for 
hepcidin and ferritin concentration via validated porcine enzyme-linked immunosorbent assay 
(ELISA) kits (Elabscience, Hubei Province, China), with a detection range of 1.56-100 ng/mL and 
4.69-300ng/mL for hepcidin and ferritin, respectively.  
Duplicate aliquots of liver tissue (~0.5 g each) were collected immediately following 
euthanasia on PND 32 or 61, rinsed with ice-cold phosphate buffered saline (0.01 mM), snap 
frozen in liquid nitrogen, and stored at -80°C until processing. Liver samples were processed and 
analyzed via the same validated porcine ELISA kits mentioned above for hepcidin and ferritin 
concentrations. Proximal duodenum scrapings were collected in duplicate, snap frozen, and 
stored at -80°C until processing to analyze divalent metal transporter 1 (DMT1) concentration 
via validated porcine ELISA kits (DL Develop, Jiangsu, China), with a detection range of 0.156-
10 ng/mL. All measures analyzed by ELISA kit were assessed in duplicate and run according to 
the manufacturer’s instructions. Samples with a result above the upper limit of the kits detection 
range were diluted and re-analyzed.  
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Quantitative real-time polymerase chain reaction (qRT-PCR) was utilized to quantify 
gene expression of ferritin and hepcidin in liver samples, and DMT1 in proximal duodenum 
scrapings. Frozen liver and proximal duodenum scrapings aliquots (50 to 100 mg) were placed 
into a 2 mL microcentrifuge tubes containing a 5 mm stainless steel bead and one mL of TRIzol 
reagent (Invitrogen, Carlsbad, CA) to enable tissue disruption for two minutes at 30 Hz 
(TissueLyser II, Qiagen, Valencia, CA). Ribonucleic acids (RNA) extraction was carried out 
according to manufacturer recommendations for TRIzol reagent and total extracted RNA was 
quantified using a spectrophotometer (NanoDrop ND-1000, Nano-Drop Technologies, 
Wilmington, DE). Complimentary DNA (cDNA) was transcribed from the isolated RNA using a 
high capacity cDNA Reverse Transcriptase kit (Thermo Fisher Scientific Inc., Waltham, MA) 
with samples placed in a thermocycler (Bio-Rad, Hercules, CA) set to run at 25°C for 10 
minutes, 37°C for 120 minutes, 85°C for 5 minutes, and then cooled at 4°C and held at 4°C 
overnight. Samples were then removed and kept at -20°C until plating. The TaqMan Gene 
Expression Assay (Thermo Fisher Scientific Inc., Waltham, MA) was used to perform qRT-PCR 
to quantify relative gene expression of porcine target genes hepcidin, ferritin, and DMT1 
(HAMP, FTH1, and SLC11A2, respectively) and the reference gene β-actin (Applied 
Biosystems, Carlsbad, CA) (19). Sample cDNA was amplified using TaqMan (Thermo Fisher 
Scientific Inc., Waltham, MA) oligonucleotide probes containing 5ʹ fluorescent reporter dye (6-
FAM) and 3ʹ non-fluorescent quencher dye, and fluorescence was determined using a 
QuantStudio 7 Flex Real-Time PCR System (Applied Biosystems, Foster City, CA). To 
normalize gene expression, parallel amplification of endogenous β-actin was performed in 
triplicate for each sample. Relative gene expression was then calculated using the comparative 
threshold cycle method (20) and results are expressed as fold-change relative to CONT pigs.   
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Following sample collection procedures at the end of phase 1, 9 pigs per treatment group 
were used to perform a carcass composition analysis at the University of Illinois Meat Science 
Laboratory (Urbana, IL) using standardized procedures. Specifically, carcasses were skinned by 
hand and an air skinner was utilized to leave subcutaneous fat with the carcass. The head, feet, 
testicles, and heart were then removed, leaving only muscle, fat, and associated connective tissue 
(i.e., total soft tissue), which was used to collect a standardized final carcass weight. All bones 
were separated from soft tissue and knife-scraped to remove residual tissue. Dissected carcasses 
were divided and weighed, with categories including skin, bone, and soft tissue. Soft tissue was 
prepared for proximate composition analysis by grinding and homogenizing all soft tissue 
through a commercial bowl chopper. A 10 g sample of soft tissue was oven-dried at 110°C for 
approximately 24 h to determine percentage moisture. The dried sample was then washed 
multiple times in an azeotropic mixture of warm chloroform:methanol as described by Swensen 
et al. (19) to determine fat content of the soft tissue. Finally, the percentage of carcass weight 
categorized as fat vs. fat-free lean was calculated for each pig. 
Statistical Analysis 
All researchers involved in this study (i.e., those performing daily procedures, data 
collection, and data analysis steps) remained blinded to dietary treatment identity until final data 
analyses had been completed. Data were analyzed using the MIXED procedure of SAS (version 
9.4, SAS Institute, Cary, NC). Replicate was considered a random variable. Hematological and 
bodyweight outcomes were collected from the same pig at multiple time-points, and thus were 
analyzed using a 2-way repeated measures ANOVA. Interactive effects were defined as an 
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interaction between diet (CONT vs. ID) and PND. All other data were collected at a single time-
point, and thus were analyzed using a one-way ANOVA to determine the effect of phase 1 dietary 
iron status. Nine pigs were omitted from tissue analysis procedures due to failure to thrive or 
complications during neuroimaging procedures. Data were analyzed for outliers (defined as having 
a studentized residual with an absolute value greater than 3) and outliers were removed prior to 
statistical analysis. Significance was accepted at P ≤ 0.05, trends were defined as 0.05 < P < 0.10, 
and data are presented as least-squares means with pooled standard errors of the mean (SEM).  
3.4 RESULTS 
Growth Performance 
 A repeated-measures ANOVA revealed an interaction effect of dietary iron status and 
PND (P < 0.001). Significant effects on body weight for diet (P < 0.001) and PND (P < 0.001) 
were observed, with ID pigs weighing less than CONT pigs. Separation between the CONT and 
ID groups on bodyweight were statistically different by PND 15 (P = 0.03), with ID pigs 
weighing less than CONT pigs from that time-point and continuously through PND 61 (Figure 
3.2). 
All growth performance data are presented in Tables 3.1 and 3.2. Average daily gain 
(ADG, P < 0.001), average daily feed intake (ADFI, P < 0.001), and the efficiency of weight 
gain (i.e., gain-to–feed ratio, G:F; P < 0.001) were consistently lower in ID pigs during phase 1. 
During phase 2, ID pigs had lower ADG (P = 0.03) and ADFI values (P = 0.003), but tended to 
have higher G:F (P = 0.066). From PND 3 to 61, ADG and ADFI were lower (P < 0.001) for ID 
pigs compared to CONT pigs, but no treatment effects were observed for G:F (P = 0.150) from 
PND 3 to 61.  
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Organ Characteristics and Body Composition  
Organ weights were analyzed on an absolute basis, as well as a proportion relative to 
individual pig body weights, due to significant effects observed (Table 3.3). On an absolute 
basis, no differences were observed between treatment groups for brain weight at PND 32 (P = 
0.268) or 61 (P = 0.136), however, ID pigs had smaller liver (P ≤ 0.01) and small intestine (P ≤ 
0.01) weights at both time-points. Relative to body weight, ID pigs had a larger (P ≤ 0.001) 
proportion attributed to the brain than did CONT pigs. Further, ID pigs had higher relative liver 
(P = 0.009) and small intestine (P = 0.006) weights on PND 61, but not PND 32. Carcass weight 
(P = 0.001), raw bone weight (P = 0.002), fat weight (P = 0.001), and lean weight (P = 0.002) 
were all reduced in ID pigs at PND 32 (data not shown), but no differences were observed 
between treatment groups for percentage carcass fat (P = 0.322) or percentage carcass fat-free 
lean (P = 0.347) (Figure 3.3). 
Hematological Outcomes 
Time-dependent hematocrit (Hct) and hemoglobin (Hb) data are presented in Figure 3.4. 
Interactive effects of dietary iron status and PND were observed for both Hct (P < 0.001) and Hb 
(P < 0.001). Effects of diet (P < 0.001) and PND (P < 0.001) were also observed in Hct and Hb. 
Hct and Hb values varied throughout the study. A clear separation between dietary groups was 
observed for both Hct and Hb by PND 21, with ID pigs having lower Hct (P < 0.001) and Hb (P 
< 0.001) concentrations compared with CONT pigs. This continued through the last time-point 
of phase 1, but this effect was fully recovered by PND 56.  
Clinical blood chemistry data are presented in Table 3.4. Interactive effects of dietary iron 
status and PND (P ≤ 0.01) were observed for sodium and creatinine. Postnatal day had a 
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significant main effect on all hematological outcomes (P ≤ 0.01). Main effects of diet were 
observed with sodium (P = 0.002), chloride (P = 0.041), ionized calcium (P < 0.001), and 
creatinine (P < 0.001) all being decreased in ID pigs compared with CONT pigs. The decrease in 
sodium was first observed on PND 28 (P < 0.001), and fully recovered by PND 56 (P = 0.937). 
Chloride was decreased (P = 0.028) on PND 21 only. Ionized calcium was lower (P = 0.012) in 
ID pigs at PND 14, but fully recovered by PND 56 (P = 0.725). The drop in creatinine values in 
ID versus CONT pigs was first observed at PND 21 (P = 0.034) and remained lower through 
PND 56.  
Peripheral Biomarker Outcomes 
 Analysis of peripheral biomarkers displayed no differences in the following: DMT1 (P = 
0.229) in the proximal duodenum, and hepcidin (P = 0.569) and ferritin (P = 0.446) in the liver 
at PND 32. No significance was observed in DMT1 (P = 0.109) in the proximal duodenum, or in 
hepcidin (P = 0.515) and ferritin (P = 0.737) in the liver at PND 61. Analysis of serum hepcidin 
and ferritin were not above detectable limits with the ELISA kits that were used (Table 3.5).  
Analysis of peripheral mRNA gene expression biomarkers displayed no difference (P = 
0.593) in ferritin, but decreased (P = 0.037) hepcidin was observed in the liver of ID pigs 
compared with CONT pigs at PND 32. In the proximal duodenum, DMT1 was trending higher 
(P = 0.091) in ID pigs at PND 32 compared to CONT pigs. No differences were observed in 
ferritin (P = 0.920) or hepcidin (P = 0.199) in the liver, or in DMT1 (P = 0.909) in the proximal 
duodenum between ID and CONT pigs at PND 61. All gene expression data are reported as fold-
change relative to endogenous β-actin expression of the CONT group within time-point (Table 
3.6). 
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3.5 DISCUSSION 
This study utilized the biomedical pig model to assess the effects of early-life IDA and if 
recovery of hematological parameters and growth performance is possible with dietary iron 
repletion later in life. A novel aspect of this study is the longitudinal assessment and ability to 
quantify whether compensation for early-life iron deficiency was possible through dietary iron 
repletion. Our results indicate that although blood characteristics quickly recover, the effects of 
iron deficiency on various growth parameters remain evident later in life.   
Growth Performance  
 Body weight did not differ between groups at the beginning of the study and for the first 
two weeks of life. Once IDA was clearly established in the ID group by PND 15, ID pigs began 
displaying reduced body weights compared with CONT pigs; an effect that remained through 
study conclusion. Interestingly, these differences in body weight persisted despite dietary iron 
repletion occurring halfway through the trial. Feed intake was also reduced in ID pigs beginning 
in the second week of life and essentially lasting through study conclusion. This is reflected in 
decreases in both ADG and ADFI during phase 1, phase 2, and overall, which is congruent with 
other studies in young pigs (7) and in human infants (20). However, one study evaluating the 
effects of iron on cognition in iron-adequate, mildly-deficient, and severely-deficient young pigs 
did not report effects in growth performance, though this could be due to a method of feeding 
that was calorically restricted based on body weight (6). Importantly, the efficiency of body 
weight gain was lower in ID pigs, but only during phase 1 (i.e., when the iron deficiency was 
applied) and not during phase 2 (i.e., the iron repletion period). This suggests compensatory body 
weight gain may have occurred with iron repletion. As growth is one of the most basic and most 
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sensitive indicators of overall metabolism and health status (21), this is of major concern for 
infant development. These findings contribute to the concept that iron is an essential nutrient for 
proper growth and development. 
Organ Characteristics and Body Composition 
 On an absolute basis, brain weight did not differ at either time-point between the CONT 
and ID groups. This was interesting in that the body weights of the two groups were so starkly 
different. When analyzed on a relative basis, however, brain weight amounted to a greater 
proportion of body weight in ID pigs compared with CONT pigs at both PND 32 and 61. This 
suggests that brain growth was somewhat preserved in ID pigs, with a greater priority of 
nutrients being partitioned into brain development versus other organs in the body. The effects of 
energy partitioning have been well-studied in animal models (22) as well as in the infant (23,24). 
On an absolute basis, both liver and small intestine weights were reduced in ID pigs compared 
with CONT pigs at both time-points. Interestingly, on a relative basis, liver and small intestine 
weights of ID pigs did not differ from CONT pigs at PND 32, but were a higher relative 
proportion of body weight than CONT pigs at PND 61. This finding suggests that after the 
period of early-life iron deficiency, there was a time of compensatory liver and small intestine 
growth once iron was replete in the diet that carried out through study conclusion. Therkildsen 
and colleagues previously observed a similar phenomenon of compensatory growth in pigs after 
a time of feed restriction (25).  
 When analyzing body composition, it was clear that IDA had a significant effect between 
the two groups. Absolute carcass, raw bone, fat, lean, and bone mass weights were all decreased 
in ID pigs compared with CONT pigs at PND 32. This finding complements the decreased body 
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weights in ID pigs observed throughout phase 1 of the study. It was expected that ID pigs would 
be leaner than CONT pigs to make up for the conservation of brain development (26,27), but 
interestingly, on a percent basis, fat and fat free lean were not different between groups at PND 
32. This is in contrast to Bauer and colleagues who found that brain sparing in intrauterine 
growth-restricted pigs was present in conjunction with decreased muscle mass (28). It has been 
well established in cases of intrauterine growth models or animals with insufficient nutrient 
provision that blood flow is redirected, such that vital organs like the brain receive increased 
blood flow, and blood flow to peripheral tissues, like muscle, is decreased (26,29). It is unclear 
why a similar effect of decreased carcass fat-free lean (i.e., representing decreased muscle mass) 
was not observed in the current study, and future work should seek to elucidate this finding. To 
our knowledge, there do not appear to be any other studies that have assessed overall body 
composition outcomes in an ID pig model.  
Hematological Outcomes 
 Hemoglobin is a standard measure used to evaluate iron status and diagnose anemia (2). 
For pigs, a Hb concentration of 9 g/dL and above is considered adequate, and a level at which 
optimal performance may occur (30). Borderline anemia is indicated at 8 g/dL, and anemia is 
diagnosed at 7 g/dL and below (30,31). Hb values of 6 g/dL or less are associated with decreased 
growth performance and, if low enough, increased mortality (30,32). At PND 7, all pigs on study 
displayed adequate Hb values, and exhibited a drop to borderline anemia by PND 14. This was 
expected, as Miller and colleagues reported that Hct and Hb levels typically fall approximately 
25% after birth (33). Such an effect is avoided in the swine industry as it is the standard 
agricultural practice to administer approximately 250 mg of iron via iron dextran i.m. to every 
pig shortly after birth to prevent anemia in nursing pigs (32). No pigs in our study received iron 
 54 
 
dextran due to iron being the nutrient of interest, and pigs only had access to iron via the diet 
throughout the study. Through PND 21, CONT pigs maintained optimal Hb concentrations, 
while ID pigs exhibited a stark decrease to levels characterized as severe anemia (30) by this 
time-point. The exceedingly low Hb value in ID pigs were reflected in decreased growth 
performance as Victor and colleagues (30) suggested, and these effects on growth performance 
were maintained even after dietary iron repletion, though Hb concentrations of ID pigs were 
normalized to match CONT pigs by study conclusion. Thus, while hematological outcomes may 
be recovered via dietary iron repletion, the detrimental effects of iron deficiency anemia on 
growth and development remain.  
 Hematocrit is another hematological test frequently used to assess iron status in 
conjunction with Hb (17,34). Pigs in the current study displayed Hct values that followed a 
similar pattern as Hb in the ID and CONT pigs, with a distinct separation of treatments occurring 
on PND 21. Notably, CONT pigs exhibited increased Hct values compared with ID pigs. This 
carried through the end of phase 1. Ventrella et al. found that Hct levels were approximately 
20% for five day old pigs and 29% for pigs thirty days of age (11). Our pigs displayed higher Hct 
levels at PND 7 compared with five-day-old, sow-reared pigs (11). While porcine milk contains 
only low iron concentrations (33), milk consumption by pigs through nursing the sow likely 
explains the discrepancy in Hct values between studies. At PND 21 and 28, CONT pigs 
displayed Hct levels comparable with Ventrella and colleagues’ thirty-day-old pigs (11) while 
Hct values of ID pigs dropped well below this range to 14% by the end of phase 1. The observed 
decline in Hct of ID pigs followed a similar pattern to severely ID young pigs in another study 
evaluating the effects of early-life iron deficiency (6). Similar to our study, Rytych et al. did not 
provide their severely ID group with an iron dextran injection (6), and they provided a diet 
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similar in iron content to that which was provided in our study. Thus, this further establishes that 
our ID pigs were in a severely anemic state by PND 32. By PND 56, Hct values were recovered 
in ID pigs to a value not different than CONT pigs, which speaks to the effects of dietary iron 
repletion. Thus, it appears that hematological outcomes influenced by early-life iron deficiency 
are able to recover upon dietary iron repletion.  
Analysis of electrolytes in the blood revealed decreased levels of creatinine, ionized 
calcium, sodium, and chloride in ID pigs compared to CONT pigs, with creatinine values 
decreased in ID pigs from PND 21 through study conclusion. IDA was clearly established in the 
ID group by PND 21. Further, stunted growth was seen in the current study from PND 15 to 61, 
with ID pigs displaying lower body weights compared with CONT pigs. It has been established 
that severe malnutrition and stunted growth in children can contribute to decreased creatinine 
levels (35). Taken together, this could explain why ID pigs had a noticeable drop in creatinine 
that carried through the end of phase 2. To our knowledge, there do not appear to be any studies 
in the pig model evaluating normal ionized calcium concentrations in the blood. Thus, it remains 
unclear why lower values were observed in the ID group. However, it is well established that 
ionized calcium is involved in muscle contraction (36,37), and circulating ionized calcium is 
critical for facilitating muscle function (38). Therefore, the lower muscle mass of the ID pigs 
may contribute to the lower concentration of ionized calcium as well. Decreases in sodium and 
chloride were observed in the ID group compared with CONT pigs. With regard to sodium, ID 
pig’s concentrations still fell within range of a previous study by Ventrella and colleagues 
looking to establish clinical reference ranges for the biomedical piglet model (11). Sodium in the 
body is tightly regulated to avoid mortality (39). Taken together, these data suggest that pigs 
were within an acceptable sodium range to avoid mortality, however, ID pigs may have been 
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effected by hyponatremia. In humans, decreases in blood chloride and sodium values have been 
observed in cases of excess loss of body fluids such as prolonged diarrhea (40). It should also be 
noted that blood sodium concentrations are closely related to chloride levels (40), thus, the 
decrease in sodium could have contributed to the decrease in chloride in ID pigs during phase 1. 
Although urine samples were not evaluated for electrolytes, it is possible that ID pigs had greater 
fluid loss than CONT pigs, thus explaining the observation of decreased sodium and chloride 
levels. Future studies looking specifically at urine loss and diarrheal episodes in ID pigs are 
needed to verify this finding. 
Peripheral Biomarker Outcomes 
Despite a clear response to IDA in the ID pigs on trial, biological responses were not 
detected in protein expression analysis of hepcidin, DMT1, or ferritin using validated porcine-
specific ELISA kits on tissues collected at PND 32. Gene expression analysis yielded no 
biological response of ferritin in ID pigs, though DMT1 was trending higher and hepcidin 
mRNA expression was lower in ID pigs compared with CONT pigs. We expected that hepcidin 
concentrations, both in circulation and in the liver, would be decreased in ID pigs to allow for 
greater iron absorption when pigs were exhibiting the strongest signs of IDA (i.e., at the end of 
phase 1). Hepcidin is known to regulate iron status by binding to ferroportin in high iron 
environments and therefore decrease absorption to prevent iron overload (36). Conversely, in 
cases of iron deficiency, hepcidin expression is suppressed to allow increased iron absorption 
(43). Though protein expression analysis did not reflect this, decreased gene expression of 
hepcidin was observed in the liver of ID pigs compared with CONT pigs. This finding is 
congruent with a study performed by Nicolas et al., who found decreased gene expression of 
hepcidin in ID mice (44). Moreover, DMT1 expression was expected to increase in the 
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duodenum to allow greater iron absorption (45) in ID pigs at PND 32, as this has been 
established as a trademark response in an attempt to counteract the onset of an ID state (46). 
Further, Jiang and colleagues noted a marked increase of DMT1 mRNA expression in proximal 
duodenum scrapings of ID Belgrade rats, further backing this notion (47). Though protein 
expression analysis did not yield any differences between the ID and CONT group, gene 
expression suggested a trend for higher DMT1 gene expression in the ID group. Finally, serum 
ferritin is currently considered a highly-sensitive biomarker for iron deficiency (48), directly 
correlating to the body iron stores (17,49), and it is well established that iron deficiency 
decreases both tissue (i.e., stored) and circulating ferritin concentrations (36). Taken together, 
despite the decline in hepcidin and increase in DMT1 to allow for greater uptake of iron, levels 
of circulating and storage ferritin were expected to drop in the ID group at PND 32 due to the 
severity of IDA. The decrease in ferritin due to iron deficiency has been observed in pigs (50) 
and human infants (51,52). Further, it has been well established that a decline in serum ferritin, 
and thus storage ferritin, occurs before a decrease in Hb is observed. This confirms the thought 
that a similar effect should have been observed at the PND 32 time-point in ID pigs established 
by Hct and Hb values decreased enough to be experiencing severe anemia. Thus, it is surprising 
that neither protein nor gene expression analyses yielded decreased ferritin outcomes in ID pigs 
compared with CONT pigs. Although colorimetric analyses were not quantified, anecdotal visual 
evidence confirms decreased liver iron content at PND 32 and apparent recovery in pigs assigned 
to the ID group as compared with CONT pigs (Supplementary Figure 3.1). Consequently, after 
dietary iron repletion, we expected ID pigs would have concomitant increases in serum ferritin 
and hepcidin, and decreased DMT1 concentrations to match CONT pigs by PND 61. This effect 
was observed in gene expression of hepcidin, with concentrations recovering to a value not 
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different than CONT pigs. However, these findings warrant further research to establish why 
expected increases in DMT1, declines in ferritin, and more substantial evidence of decreases in 
hepcidin were not observed in both protein and gene expression. Furthermore, the amount of 
recovery time required to fully reverse blood and tissue indicators of early-life iron deficiency 
remains to be seen. 
Conclusions 
Our study made use of a severely-anemic pig model using only a low-iron diet. We 
observed stark decreases in Hct and Hb concentrations in ID pigs after the first two weeks of life 
and lasting through the end of phase 1, but Hct and Hb both quickly recovered to levels 
equivalent to CONT pigs after dietary iron repletion during phase 2. However, early-life IDA 
caused long-lasting effects on growth and organ characteristics in the pig. As such, ID pigs 
exhibited severely decreased feed intake and body weight gain compared with CONT pigs, and 
these effects remained even after dietary iron repletion. These findings suggest that early-life ID 
disrupts growth performance for a period of time longer than the amount of time spent in an 
anemic state. These findings confirm not only that iron is an essential nutrient for proper growth 
and development, but that some outcomes are responsive to iron repletion while others are not. 
Protein and mRNA gene expression outcomes of biomarkers known to be involved in iron 
uptake and storage did not provide definitive evidence in our pigs, though others have reported 
conclusive evidence on how iron deficiency effects these biomarkers across multiple species. 
The young pig proved to be an appropriate translational model to study the effects of nutrient 
deficiencies, specifically iron, and how deficiencies may affect development of both young pigs 
and human alike. Furthermore, it highlights a critical window in which iron is imperative to 
ensure proper growth of the neonate. Future studies are needed to evaluate whether growth can 
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be fully recovered with a longer time spent on an iron replete diet. Moreover, future work should 
seek to evaluate the effects of IDA on DMT1, hepcidin, and ferritin to establish reference ranges 
for the pig as a biomedical subject, whether these biomarkers can quickly recover after iron 
repletion in the diet, and how long repletion is necessary to fully recover liver iron status. 
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3.6 TABLES 
 
 
 
 
  
Table 3.1. Growth performance of pigs differing in early-life iron status1 
 Diet  Pooled  
Measure CONT ID   SEM P-value2 
PND 3-33      
   ADG, g/day 403 190  12.3 < 0.001 
   ADFI, g liquid/day 1739 935  50.6 < 0.001 
   G:F, g BW:g solids 1090 950  26.5 < 0.001 
PND 3-7      
   ADG, g/day 102 95  29.0 0.713 
   ADFI, g liquid/day 994 913  136.1 0.372 
   G:F, g BW:g solids 388 483  191.9 0.520 
 PND 7-14      
   ADG, g/day 172 109  14.2 0.004 
   ADFI, g liquid/day 1014 774  60.7 0.008 
   G:F, g BW:g solids 844 640  88.9 0.114 
PND 14-21      
   ADG, g/day 447 197  17.7 < 0.001 
   ADFI, g liquid/day 1770 894  76.2 < 0.001 
   G:F, g BW:g solids 1210 1066  103.0 0.170 
PND 21-28      
   ADG, g/day 628 300  30.1 < 0.001 
   ADFI, g liquid/day 2892 1408  90.8 < 0.001 
   G:F, g BW:g solids 1029 1018  81.2 0.888 
PND 28-33      
   ADG, g/day 610 269  25.0 < 0.001 
   ADFI, g liquid/day 2988 1270  177.0 < 0.001 
   G:F, g BW:g solids 960 893  138.9 0.504 
1Data presented as mean and pooled standard error of the means (SEM) 
for each dietary treatment group. Main effects of dietary treatment (Diet; 
CONT vs ID) is presented. Abbreviations: CONT, control diet; ID, iron 
deficient diet; SEM, standard error of the mean; PND, postnatal day; 
BW, body weight; ADG, average daily gain; ADFI, average daily feed 
intake; G:F, gain-to-feed ratio or efficiency of body weight gain. 
Calculations reflect a reconstitution rate of 20% solids for milk replacer 
treatments administered from PND 3-33 (phase 1 of the study). 
2P-values derived from mixed model ANOVA. 
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Table 3.2. Growth and feeding performance on standard industry diet1 
 Diet  Pooled  
Measure CONT ID  SEM P-value2 
PND 3-61      
   ADG, g/day 476 329  15.0 < 0.001 
   ADFI, g solids/day 1128 669  58.9 < 0.001 
   G:F, g BW:g solids 1690 1786  58.1 0.150 
PND 33-61      
   ADG, g/day 544 470  22.0 0.030 
   ADFI, g solids/day 912 733  52.0 0.003 
   G:F, g BW:g solids 599 646  32.3 0.066 
PND 35-42      
   ADG, g/day 213 200  33.8 0.791 
   ADFI, g solids/day 678 524  65.8 0.010 
   G:F, g BW:g solids 322 381  51.4 0.426 
PND 42-49      
   ADG, g/day 536 514  43.9 0.734 
   ADFI, g solids/day 864 710  97.0 0.053 
   G:F, g BW:g solids 643 723  105.3 0.157 
PND 49-56      
   ADG, g/day 849 671  87.3 0.004 
   ADFI, g solids/day 1252 1024  161.7 0.029 
   G:F, g BW:g solids 683 670  27.5 0.729 
PND 56-61      
   ADG, g/day 902 750  91.4 0.097 
   ADFI, g solids/day 1614 1364  91.9 0.038 
   G:F, g BW:g solids 579 548  93.4 0.535 
1Data presented as mean and pooled standard error of the means (SEM) for 
each dietary treatment group. Main effects of dietary treatment (Diet; CONT 
vs ID) is presented. Abbreviations: CONT, control diet; ID, iron deficient 
diet; SEM, standard error of the mean; PND, postnatal day; BW, body 
weight; ADG, average daily gain; ADFI, average daily feed intake; G:F, 
gain-to-feed ratio or efficiency of body weight gain. Calculations reflect a 
reconstitution rate of 20% solids for milk replacer treatments administered 
from PND 3-33 (phase 1 of the study). 
2P-values derived from mixed model ANOVA. 
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Table 3.3. Organ characteristics of pigs differing in early-life iron status1  
  Diet Pooled 
SEM 
 
Measure N2 CONT ID P-value3 
Absolute      
PND32      
  BW, kg 19 13.18 7.22 0.363 <0.001 
 Brain, g 11 53.43 50.57 1.774 0.268 
   Liver, g 9 337 181 21.4 0.001 
   Small intestine, g 13 578 309 63.3 0.011 
PND61      
  BW, kg 10 29.4 20.8 0.89 <0.001 
   Brain, g 19 68.38 65.44 1.358 0.136 
   Liver, g 11 767 587 41.2 0.011 
  Small intestine, g 19 964 813 54 0.008 
Relative to BW      
PND32      
   Brain, % of BW 11 0.43 0.75 0.053 0.001 
   Liver, % of BW 9 2.88 2.77 0.195 0.672 
  Small intestine, % of BW 13 3.95 4.64 0.280 0.102 
PND61      
   Brain, % of BW 19 0.24 0.32 0.011 <0.001 
   Liver, % of BW 11 2.55 2.81 0.058 0.009 
  Small intestine, % of BW 19 3.30 3.95 0.149 0.006 
1Data presented as mean and pooled standard error of the means (SEM) for 
each dietary treatment group. No interactive effects involving time were noted, 
so only main effects of dietary treatment are presented. Abbreviations: CONT, 
control diet; ID, iron deficient diet; PND, postnatal day; SEM, standard error of 
the mean; BW, body weight. 
2Total number of observations used. 
3P-values for the main effect of early-life dietary iron concentration. 
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Table 3.4.  Clinical blood chemistry outcomes of pigs differing in early-life iron status1  
 
  CONT  ID        
  PND  PND Pooled  P-value3 
Measure N2 7 14 21 28 35 56  7 14 21 28 35 56 SEM PND Diet Interaction 
Clinical outcomes                   
 Sodium, mmol/L 176 141b 137a  137a 140b 141b 142b  142b 137a 136a 137a 136a 142b 1.1 < 0.001 0.002 0.007 
 Potassium, mmol/L 171 5.2 5.7 6.1 6.0 5.7 6.6  5.6 5.8 5.7 5.9 5.7 6.4 0.36 0.010 0.849 0.645 
   Chloride, mmol/L 177 102 101 101 102 105 102  103 98 97 100 104 103 1.9 0.002 0.041 0.347 
   Ionized calcium, mmol/L 175 1.24 1.17 1.25 1.28 1.25 1.40  1.22 1.09 1.18 1.20 1.15 1.38 0.081 < 0.001 < 0.001 0.427 
   Total carbon dioxide, mmol/L 174 28 27 23 24 23 27  28 28 26 23 20 28 1.3 < 0.001 0.749 0.099 
  Glucose, mg/dL 175 103 111 127 128 124 117  103 109 114 119 112 127 5.6 < 0.001 0.070 0.073 
   Urea nitrogen, mg/dL 145 23 10 7 12 7 6  22 11 6 9 12 6 3.5 < 0.001 0.955 0.747 
   Creatinine, mg/dL  176 0.5a 0.6a 0.7b 0.8c 1.3e 1.0d  0.6a 0.5a 0.6a 0.7b 1.1d 0.8bc 0.05 < 0.001 < 0.001 0.010 
Hematology                   
   Hematocrit, %PCV 147 27c 23b 26c 32d -* 36e  27c 20b 16a 14a -* 35de 1.4 < 0.001 < 0.001 < 0.001 
   Hemoglobin, g/dL  146 9.1c 7.7b 8.7c 10.9d -* 12.1e  9.3c 7.0b 5.5a 4.7a -* 11.9de 0.46 < 0.001 < 0.001 < 0.001 
1Data presented as mean and pooled standard error of the means (SEM) for each dietary treatment group. Main effects of dietary treatment (Diet; CONT vs ID) and PND, and the interaction 
between Diet and PND are presented. a-eLabeled means in a row without a common superscript letter differ, P < 0.05.  Abbreviations: CONT, control diet; ID, iron deficient diet; PND, postnatal 
day; SEM, standard error of the mean. 
2Total number of observations used. 
3P-values for the main and interactive effects of early-life dietary iron concentration. 
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Table 3.5. Iron-related protein expression (µg/g protein) from pigs differing in early-
life iron status1  
  Diet 
Pooled SEM 
 
Measure N2 CONT ID P-value3 
PND 32      
  Proximal Duodenum       
     DMT1 13 0.34 0.23 0.060 0.229 
  Liver       
     Hepcidin  13 55.75 69.28 32.727 0.569 
     Ferritin 13 714.09 876.97 150.780 0.446 
PND 61      
  Proximal Duodenum       
     DMT1 20 0.51 0.34 0.071 0.109 
  Liver       
     Hepcidin 20 27.23 31.11 4.136 0.515 
     Ferritin 20 628.66 565.85 130.200 0.737 
1Data presented as mean and pooled standard error of the means for each dietary 
treatment group. Main effects of dietary treatment (Diet; CONT vs ID) are presented. 
Abbreviations: CONT, control diet; ID, iron deficient diet; PND, postnatal day; 
SEM, standard error of the mean; DMT1, divalent metal transporter. 
2Total number of observations used. 
3P-values for the main effect of early-life dietary iron concentration.  
 65 
 
 
 
 
 
 
 
 
Table 3.6. Iron-related gene expression relative from pigs differing in early-life iron 
status1  
  Diet Pooled 
SEM 
 
Measure N2 CONT ID P-value3 
PND 32      
  Proximal Duodenum       
     DMT1 9 1.00 2.37 0.508 0.091 
  Liver       
     Hepcidin  11 1.00 0.27 0.497 0.037 
     Ferritin 11 1.00 0.81 0.256 0.593 
PND 61      
  Proximal Duodenum       
     DMT1 14 1.00 1.08 0.545 0.909 
  Liver       
     Hepcidin 18 1.00 0.66 0.181 0.199 
     Ferritin 18 1.00 1.02 0.133 0.920 
1Gene expression values calculated as fold-change relative to endogenous expression 
of β-actin of control pigs within each time-point. Data presented as mean and pooled 
standard error of the means for each dietary treatment group. Main effects of dietary 
treatment (Diet; CONT vs ID) are presented. Abbreviations: CONT, control diet; ID, 
iron deficient diet; PND, postnatal day; SEM, standard error of the mean; DMT1, 
divalent metal transporter. 
2Total number of observations used. 
3P-values for the main effect of early-life dietary iron concentration.  
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3.7 FIGURES 
 
 
Figure 3.1. Analyzed concentrations of iron in porcine and human milks, as well as in dietary 
treatments during both phases of the pig study. During phase 1, pigs were fed either a control 
(CONT) or iron-deficient (ID) milk replacer. The CONT treatment contained 21.3 mg/L (106.3 
mg/kg), and the ID treatment contained 2.72 mg/L (13.6 mg/kg). The ID treatment closely 
resembled the average iron content of porcine milk (n=7; 1.06 mg/L) collected during a prior study 
[16], and is comparable to the iron concentration of human milk [17,18]. During phase 2, all pigs 
were fed a series of standard commercial starter diets (180-300 mg/kg). Abbreviations: CONT, 
control; ID, iron deficient; PND, postnatal day. 
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Figure 3.2. Effect of early-life iron status on pig body weight. Early-life dietary iron status has 
long-lasting influences on pig body weight for a time longer than the period spent in an ID state. 
Interactive effects of diet and PND were observed (P < 0.001), and SEM error bars are present. 
Abbreviations: CONT, control; ID, iron deficient; PND, postnatal day; SEM, standard error of the 
mean. 
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Figure 3.3. Percent fat and percent fat free lean of pigs differing in early-life iron status. Early-
life iron status did not affect body composition in young pigs despite differences in overall 
bodyweight. No effects of dietary iron status were observed for percent carcass fat (P = 0.322) or 
percent carcass fat-free lean (P = 0.347). Abbreviations: CONT, control; ID, iron deficient; PND, 
postnatal day. 
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Figure 3.4. Hematocrit and hemoglobin concentrations in pigs differing in early-life iron status. 
Early-life iron status influences hematocrit and hemoglobin concentration in young pigs. 
Interactive effects of dietary iron status and PND, as well as main effects of diet and PND, were 
observed for hematocrit (P < 0.001) and hemoglobin (P < 0.001). a-eMeans without a common 
superscript letter differ, P < 0.05. Abbreviations: CONT, control; ID, iron deficient; PND, 
postnatal day; % PCV, percent packed cell volume. 
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3.8 SUPPLEMENTARY FIGURES: 
 
 
Supplementary Figure 3.1. Visual evidence of decreased liver iron content in pigs differing in 
early-life iron status. A, CONT at PND 32. B, ID at PND 32. C, CONT at PND 61. D, ID at PND 
61. Abbreviations: CONT, control; ID, iron deficient; PND, postnatal day. 
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CHAPTER 4: EARLY-LIFE IRON DEFICIENCY AND SUBSEQUENT REPLETION 
ALTERS DEVELOPMENT OF THE COLONIC MICROBIOTA IN THE PIG 
4.1 ABSTRACT 
Iron deficiency is the most prevalent micronutrient deficiency worldwide, affecting over 
two billion people. Early-life iron deficiency can lead to alterations in the developing microbiota, 
which may or may not be reversible with dietary iron repletion. Thus, the aim of this study was 
to determine whether early-life iron deficiency and subsequent repletion alter the colonic 
microbial composition and fermentation end-product concentrations in pigs. Forty-two intact 
male pigs were ad libitum fed either control (CONT, 21.3 mg Fe/L) or iron-deficient (ID, 2.72 
mg Fe/L) milk replacers from postnatal day (PND) 2 to 32 (phase 1). Twenty pigs were then 
transitioned through a series of age-appropriate, industry-standard, iron-adequate diets from PND 
33 to 61 (phase 2). Contents from the ascending colon (AC) and rectum (i.e., fresh feces) were 
collected at PND 32 and/or 61. Quantification of microbiota composition and volatile fatty acid 
(VFA) concentrations was performed at PND 32, while only VFA concentrations were assessed 
at PND 61. Data were analyzed using a 1-way ANOVA to assess the main effects of early-life 
iron status on all experimental outcomes. In AC samples, 15 genera differed (P < 0.05) between 
ID and CONT pigs, while 27 genera differed (P < 0.05) in fresh fecal samples at PND 32. Early-
life ID pigs had higher (P = 0.012) relative abundance of Lactobacillus in AC samples compared 
with CONT pigs. In feces, ID pigs had lower (P < 0.05) relative abundances of Bacteroides and 
Clostridium from the families of Clostridiaceae, Lachnospiraceae, and Ruminococcaceae. At 
PND 32, total VFA concentration was higher in ID pigs compared with CONT pigs in both AC 
(P = 0.003) and fecal (P = 0.001) samples. After dietary iron repletion at PND 61, total VFA 
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concentration did not differ in contents sampled from either the AC (P = 0.619) or rectum (P = 
0.798) between ID and CONT pigs. Early-life iron status influences both microbial composition 
and fermentation end-product concentrations within the large intestine, but these differences in 
VFA were normalized following subsequent dietary iron repletion. 
4.2 INTRODUCTION 
Early-life nutrition profoundly influences neonatal development, with some deficiencies 
leading to long-term alterations, as is the case for iron. Iron is an essential micronutrient for 
many biological processes, yet it is the leading micronutrient deficiency worldwide. Iron 
deficiency affects over two billion people, with women of childbearing age and young children 
being most vulnerable to deficiency (1,2). Maternal iron deficiency can lead to reduced iron 
stores in the infant, who is already of heightened risk of developing iron deficiency due to rapid 
growth after birth (3,4). When untreated, iron deficiency can progress to iron deficiency anemia 
(IDA), which has more severe effects on the developing neonate. Of particular interest are the 
effects of IDA on microbiota composition, which primarily develops during infancy (5). 
Moreover, a growing body of evidence suggests that iron availability within the gastrointestinal 
tract (GIT) may influence the bacterial species thriving in that environment. The microbiome is 
now known to have long-lasting effects on the host, including implications in autoimmune, 
metabolic, and gastrointestinal diseases, as well as influencing the development of allergies (5,6). 
Nearly all microbial fermentation end-products, e.g., volatile fatty acids (VFA), are produced 
within the lumen of the large intestine (7) and quantification of VFA concentrations serves as a 
sensitive indicator of shifts in overall microbial composition. As such, determining how early-
life iron deficiency followed by dietary iron repletion influences the composition of the neonatal 
microbiota is imperative to identify if iron deficiency-induced alterations are reversible.  
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The current study utilized the young pig as a translational model for the human infant. 
The pig shows marked similarities in morphology, nutrient requirements, and microbial 
composition of the GIT to the human infant (8). Further, iron deficiency is a common 
micronutrient deficiency in the young pig for many reasons that parallel those seen in the infant, 
including low levels of iron stores at birth, low iron concentration in porcine milk, heightened 
growth trajectories after birth, and immature iron absorption pathways until later in life (9). As 
such, the pig is a robust pre-clinical model for early-life iron deficiency (10–13), and a powerful 
model for early-life nutrition research (14).  
The aims of this study were to characterize the effects of early-life IDA on development 
of the microbiota and to assess if subsequent dietary iron repletion would reverse the effects of 
early-life iron deficiency. To characterize these alterations, the microbiota and fermentation end-
product profiles were evaluated at PND 32, and fermentation end-product profiles were again 
evaluated at study conclusion.  
4.3 MATERIALS AND METHODS 
Animal Care and Use 
All animal and experimental procedures were in accordance with the National Research 
Council Guide for the Care and Use of Laboratory Animals and approved by the University of 
Illinois at Urbana-Champaign Institutional Animal Care and Use Committee. Forty-two naturally-
farrowed, intact male pigs were obtained from a commercial swine farm in two replicate groups 
and transferred to the University of Illinois Piglet Nutrition and Cognition Laboratory (PNCL) at 
PND 2. Nine pigs were omitted from tissue analysis due to failure to thrive or complications during 
experimental procedures that are reported elsewhere (15,16). Per standard agricultural protocol, 
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pigs were administered a single intramuscular injection of antibiotic (0.1 mL of ceftiofur 
crystalline free acid as Excede, Zoetis, Parsippany, NJ) within 24 h of birth. Contrary to typical 
agricultural procedures, pigs on this study were never provided supplemental iron (i.e., injectable 
iron dextran) due to our experimental focus on this nutrient. Recent pig studies observed 
hippocampal transcriptome changes (17) and possible effects of iron overload (11) after iron 
dextran administration in the first few days of life, which further justifies our experimental 
protocol. Upon arrival to PNCL on PND 2, pigs were randomized to one of two experimental milk 
replacer treatments (described below). Pigs were provided experimental milk replacer treatments 
from PND 2 until PND 32 or 33 (phase 1), at which point both treatment groups were transitioned 
through a series of industry-standard diets from PND 32 or 33 until PND 61 or 62 (phase 2).  
For phase 1 of this study, 42 piglets were housed individually in custom pig rearing units 
(87.6 cm long, 88.9 cm wide, 50.8 cm high), which were composed of three acrylic walls, one 
stainless steel wall, and vinyl-coated, expanded metal flooring. This caging environment was 
designed for pigs to see, hear, and smell, but not touch neighboring pigs. Pigs were allowed to 
physically interact with one another for approximately 15 min each day, and each pig was provided 
a toy for enrichment in their home-cage throughout the study. Facility lighting was maintained on 
a 12 h light and dark cycle starting at 0800, with ambient temperature set at 27°C for the first 21 
days of the study and gradually lowered to 22°C during the last seven days of phase 1.  
For phase 2 of this study, 20 pigs (n = 10 per phase 1 diet) from phase 1 were transferred 
to the University of Illinois Veterinary Medicine Research Farm on PND 32 or 33 until the end of 
the study. While in this facility, pigs were housed individually in floor pens (1.5 m2) and the rearing 
environment remained on a 12 h light and dark cycle starting at 0800, with ambient temperature 
set at 22°C.  
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Dietary Treatments 
For phase 1 of this study, pigs (n = 21 per diet) were provided one of two milk replacer 
treatments with varying iron content. The control diet (CONT) was formulated to meet all of the 
nutrient requirements of the growing pig and was formulated to contain 106.3 mg Fe/kg milk 
replacer powder. The iron deficient (ID) diet was identical to the CONT diet, with the exception 
that ferrous sulfate (i.e., the predominant iron source in CONT) was removed, such that this 
treatment provided only 13.6 mg Fe/kg milk replacer powder. Additionally, both diets were 
formulated to contain ARA and DHA at 2.08 g and 1.04 g DHA/kg milk replacer powder, 
respectively. Milk replacer was reconstituted fresh daily with 200 g of milk replacer powder per 
800 g water. Thus, formulated iron concentrations in reconstituted pig milk replacer treatments 
were 21.3 and 2.72 mg Fe/L milk replacer for the CONT and ID treatments, respectively. All pigs 
were provided ad libitum access to liquid milk replacer treatments for a 20 h feeding period each 
day from PND 2 until PND 32 or 33.  
For phase 2 of this study, all pigs were transitioned through a common series of age-
appropriate, industry-relevant, iron-adequate diets (containing 180-300 mg Fe/kg of diet), 
regardless of their phase 1 dietary iron treatment group. Pigs were provided ad libitum access to 
standard diets (major ingredients including corn, whey, and soybean meal) and standard 
agricultural feeding practices were followed by sequentially switching to stage 1, 2, and 3 diets on 
PND 32, 41, and 50, respectively. During phase 2 of the study, all diets were formulated to meet 
all nutrient requirements of growing pigs (18), including iron. No zinc oxide, copper sulfate, or in-
feed antibiotics were included in any diets. Analyzed concentrations of iron in all dietary 
treatments can be found in Figure 4.1.  
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Porcine milk was collected as part of a previous study (19). Samples were then analyzed 
for mineral profiles by using standardized procedures (Mead Johnson Nutrition, Evansville, IN) to 
establish iron content. Specifically, porcine milk samples were digested using a combination of 
concentrated nitric acid and 30% hydrogen peroxide at 220°C for 10 min in a microwave digestion 
system (UltraWAVE; Milestone Inc., Shelton, CT). After digestion, the samples were diluted to 
volume and quantified by inductively-coupled plasma mass spectrometry (ICP-MS; NexION 
300D; Perkin Elmer, Waltham, MA). The instrument was operated in kinetic energy discrimination 
mode using helium to reduce polyatomic interferences. All samples were analyzed in duplicate. 
Sample Collection, Processing, and Analysis 
Fresh fecal samples were collected utilizing a fecal loop on PND 31 (CONT, n=6; ID, n=7) 
and/or PND 60 (N = 20; n = 10 per phase 1 diet), snap frozen in liquid nitrogen, and stored at -
80°C until processing. At PND 32 (CONT, n = 6; ID, n = 7) and PND 61 or 62 (N = 20; n = 10 
per phase 1 diet), pigs were euthanized to allow tissue collection. All animals were euthanized in 
a food-deprived state, with access only to water for at least 6 h prior to euthanasia. Pigs were 
anesthetized using an intramuscular injection of telazol:ketamine:xylazine administered at 0.022 
mL/kg bodyweight (50.0 mg tiletamine plus 50.0 mg of zolazepam reconstituted with 2.50 mL 
ketamine (100 g/L) and 2.50 mL xylazine (100 g/L); Fort Dodge Animal Health, Overland Park, 
KS). To ensure pigs were properly anesthetized prior to euthanasia, all pigs were tested for pain 
reflex via eye blink response. Pigs were euthanized using a 390 mg/mL sodium pentobarbital 
solution (Patterson Veterinary Supply, Columbus, OH) at 1 mL/5 kg body weight with an 
intracardiac injection. On the day of tissue collection, AC and fresh fecal samples were collected 
after euthanasia at PND 32 or PND 61, snap frozen in liquid nitrogen, and stored at -80°C until 
processing.  
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Microbiota Analysis  
DNA Extraction 
Ascending colon and fecal samples from phase 1 were utilized for microbiota analysis. 
DNA was extracted utilizing the QIAamp DNA Stool Mini Kit (Qiagen, Valencia, CA) in 
combination with the FastPrep-24 System (MP Biomedicals, Carlsbad, CA) as previously 
described (20). DNA quality was assessed on a 1% agarose gel following staining with ethidium 
bromide, and DNA concentrations were quantified using a NanoDrop 1000 spectrophotometer 
(NanoDrop Technologies, Wilmington, DE).  
PCR Amplification and Sequencing of 16S rRNA Genes 
Polymerase chain reaction (PCR) amplification and sequencing of 16S rRNA genes were 
performed at the High-Throughput Sequencing and Genotyping Unit, University of Illinois. The 
V3-V4 regions of bacterial 16S rRNA gene were amplified using primers V3f (5'-
CCTACGGGAGGCAGCAG-3') and V4r (5'-GGACTACHVGGGTWTCTAAT-3') (21) with 
appropriate linkers and sample barcodes. PCR was performed on a Fluidigm Biomark HD 
platform (Fluidigm Corporation, San Francisco, CA) as previously described (22). The 
temperature profiles include: 50°C for 2 min (1 cycle), 70°C for 20 min (1 cycle), 9°C for 10 min 
(1 cycle), followed by 10 cycles at 95°C for 15 sec, 55°C for 30 sec, and 72°C for 1 min, 2 
cycles at 95°C for 15 sec, 80°C for 30 sec, 60°C for 30 sec, and 72°C for 1 min, 8 cycles at 95°C 
for 15 sec, 55°C for 30 sec, and 72°C for 1 min, 2 cycles at 95°C for 15 sec, 80°C for 30 sec, 
60°C for 30 sec, and 72°C for 1 min, 8 cycles at 95°C for 15 sec, 55°C for 30 sec, and 72°C for 1 
min, and 5 cycles at 95°C for 15 sec, 80°C for 30 sec, 60°C for 30 sec, and 72°C for 1 min. 
Amplicons from 48 separate reactions were pooled for each sample and DNA concentration was 
 83 
 
measured on a Qubit 3.0 Fluorometer (Thermo Fisher Scientific, Waltham, MA). The size of 
amplicons was confirmed by Fragment Analyzer (Advanced Analytical Technologies, Ankeny, 
IA). The amplicons were then mixed in equimolar concentrations and run on a 2% agarose E-gel 
(Thermo Fisher Scientific, Waltham, MA). The band of expected size (ca. 460 bp) was excised 
from the gel and the DNA was extracted with gel extraction kit (Qiagen, Valencia, CA). The 
extracted DNA was run on an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, 
CA) to confirm appropriate profile and determine average size. Sequencing was performed on an 
Illumina MiSeq System using a MiSeq Reagent Nano Kit v2 (2×250 nt paired end reads; 
Illumina, San Diego, CA). 
Sequence Processing 
De-multiplexed forward (read 1) and reverse reads (read 2) obtained from the sequencing 
facility were processed using the QIIME software package (23). The paired-end reads were 
merged using SeqPrep with a minimum overlap of 30 bp. Merged reads were filtered and split 
into libraries at Phred quality score ≥ 25. Operational taxonomic units (OTUs) picking at 97% 
identity was performed using uclust (24). The representative sequences from each OTU were 
picked and the chimera sequences were identified via Chimera Slayer (25). After removal of 
chimeras, the remaining sequences were aligned to the greengenes reference alignment 
(gg_13_8_otus/rep_set_aligned/85_otus.pynast.fasta) using PyNAST (26,27). The alignment was 
then filtered to remove highly variable regions and columns comprised of only gaps using a lane 
mask. The phylogenetic tree was constructed from filtered alignment using FastTree (28). The 
representative sequence of each OTU was assigned to different taxonomic levels using 
Ribosomal Database Project naïve Bayesian rRNA Classifier (29) at 80% confidence level on the 
Greengenes reference database v.13.8. An OTU table was created and further filtered to remove 
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non-aligned and chimeric OTUs and singletons. Alpha diversity (observed OTUs, Chao1 and 
Shannon and Simpson reciprocal indices) and beta diversity analysis was performed from the 
filtered OTU table after rarefying to 26,350 reads for each sample. 
Volatile Fatty Acid Analysis 
Both AC and fecal samples from phase 1 and phase 2 were utilized to quantify VFA 
concentrations. As such, AC samples were thawed, weighed (100 mg each), and acidified with an 
equal volume of HCl. Fecal samples were thawed, weighed (100 mg each), and acidified using 
6.25% m-Phosphoric acid, sonicated, and stored overnight at -20°C. Samples were then thawed 
and centrifuged for ten min at 16,500 x g, and supernatant was collected for analysis via gas 
chromatography. All samples were assessed as previously described (30). Acetic, n-butryic, 
propionic, valeric, isovaleric, and isobutyric acid solutions were used as standards (Sigma Aldrich, 
St. Louis, MO) to quantify individual VFA concentrations.  
Statistical Analysis 
All researchers involved in this study (i.e., those performing daily procedures, data 
collection, and data analysis steps) remained blinded to dietary treatment identity until final data 
analyses had been completed. Differences in bacterial communities among diet groups were 
evaluated with principal co-ordinate analysis (PCoA) and permutational multivariate analysis of 
variance (PERMANOVA) using UniFrac distance matrices (31). PCoA and PERMANOVA were 
performed on both unweighted and weighted UniFrac distances using QIIME (23). All other data 
were analyzed using the MIXED procedure of SAS (version 9.4, SAS Institute, Cary, NC). 
Replicate was considered a random variable. All data were collected at an individual time-point, 
and thus were analyzed using a one-way ANOVA to determine the effect of phase 1 dietary iron 
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status. Relative abundances of all phyla and genera 0.05% or greater were analyzed, and were 
arcsin transformed before analysis. Outliers, defined as having a studentized residual with an 
absolute value greater than 3, were removed from the dataset prior to statistical analysis. 
Significance was accepted at P ≤ 0.05, trends were defined as 0.05 < P < 0.10, and data are 
presented as least-squares means with pooled standard errors of the mean (SEM). For relative 
abundance microbiota outcomes, data are presented as raw least-square means plus SEM, along 
with arcsin-transformed P-values. 
4.4 RESULTS 
Microbiota 
Ascending Colon 
Principal co-ordinate analysis of UniFrac distances produced from AC samples are 
shown in Figures 4.2a and b. PERMANOVA analysis revealed that overall bacterial 
composition in AC samples differed (unweighted, P = 0.003, weighted P = 0.035) between 
CONT and ID pigs. At the phyla level, no differences were observed in AC (Table 4.1). At the 
genus level, CONT pigs displayed higher (P ≤ 0.034) relative abundances of Akkermansia, 
Anaerotruncus, Barnesiella, Bilophila, Butyricimonas, Collinsella, Eggerthella, 
Parabacteroides, [Ruminococcus] (Taxa that have brackets around the names are proposed 
taxonomies that Greengenes recommended based on the whole genome phylogeny, but not 
officially recognized by Bergey’s manual of systematic bacteriology), and Sutterella, and ID pigs 
displayed higher (P ≤ 0.020) levels of Dialister, Lactobacillus, Megasphaera, Prevotella, and 
[Prevotella] in AC samples (Table 4.2). In AC samples, no differences were observed in 
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Shannon (P = 0.761) or Chao 1 (P = 0.594) indices, or in the Simpson reciprocal index (P = 
0.568) at PND 32.  
Feces  
Principal co-ordinate analysis of UniFrac distances generated from fresh fecal samples 
are shown in Figures 4.2c and d. PERMANOVA analysis revealed that overall bacterial 
composition in fresh feces (unweighted and weighted, P = 0.001) differed between CONT and 
ID pigs. At the phyla level, ID pigs had increased relative abundances in actinobacteria (P = 
0.0113), proteobacteria (P = 0.019), and an unknown phyla (P = 0.018) in feces when compared 
with CONT pigs (Table 4.1). At the genus (family) levels, CONT pigs harbored greater (P ≤ 
0.045) proportions of Akkermansia, Bacteroides, Barnsiella, Chrstensenella, Clostridium from 
the families of Clostridiaceae, Lachnospiraceae, and Ruminococcaceae, Eggerthella, 
[Eubacterium], [Ruminococcus], and Rothia, and ID pigs had increased (P ≤ 0.041) abundance 
in Acidaminococcus, Bifidobacterium, Bilophila, Coprococcus, Dialister, Escherichia, 
Faecalibacterium, Lactobacillus, Megasphaera, Mitsuikella, Oscilospira, Prevotella, 
[Prevotella], RFN20, Sharpea, and Shigella in feces (Table 4.3). Alpha diversity due to early-
life iron deficiency is presented in Table 4.4. Iron deficient pigs had higher (P = 0.016) alpha 
diversity in the Shannon index, trending higher (P = 0.071) in the Simpson reciprocal outcome, 
and no difference in the Chao 1 index (P = 0.218). Analysis of microbiota was only performed 
on samples collected on PND 32 (i.e., at the end of the early-life iron deficiency feeding phase). 
Dry Matter and Volatile Fatty Acid Composition 
Ascending Colon 
 87 
 
At PND 32, ID pigs had decreased (P = 0.006) percent dry matter (DM) in AC contents, 
and the total VFA concentration in AC contents from ID pigs was increased (P = 0.003) 
compared with CONT pigs (Table 4.5). Absolute concentrations of acetate (P = 0.002), 
propionate (P = 0.018), butyrate (P = 0.012), and valerate (P = 0.025) were more than doubled in 
AC contents of ID pigs compared with CONT pigs. Relative to total VFA (i.e., % total VFA) 
concentrations, acetate was increased (P < 0.001) in ID pigs, but a decrease (P < 0.001) in 
relative propionate was observed in AC contents. Iron deficient pigs also had lower relative 
proportions of isobutyrate (P = 0.002) and isovalerate (P = 0.001) in AC at PND 32 compared 
with CONT pigs. By PND 61, no significance was observed in the concentrations of DM (P = 
0.382), total VFA (P = 0.678), or any individual VFA on either absolute or relative bases in AC 
contents.   
Feces 
In feces, DM was decreased (P < 0.001) and total VFA concentration was increased (P = 
0.001) in feces from ID pigs compared with CONT pigs at PND 32 (Table 4.6). At the end of 
phase 1, concentrations of individual VFA on an absolute basis were increased in fresh fecal 
samples of ID pigs, including acetate (P < 0.001), propionate (P = 0.001), and valerate (P = 
0.007). Relative to the total VFA concentration, acetate was increased (P < 0.001) in ID pigs 
compared with CONT animals, and propionate (P = 0.001), butyrate (P < 0.001), isobutyrate (P 
< 0.001), and isovalerate (P < 0.001) were all decreased. At study conclusion, no effects of 
dietary early-life iron status were evident in feces, including concentrations of DM (P = 0.612), 
total VFA (P =0.719), or any individual VFA on either absolute or relative bases.  
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4.5 DISCUSSION 
Microbiota 
The diet provides nutrients for both the host and resident microbes within the lumen of 
the GIT (32), thus microbial composition of the GIT is heavily influenced by nutrition (33). 
Mounting evidence suggests that iron status alone has a significant impact on the microbiota by 
altering microbial diversity in the GIT and the growth of potentially-pathogenic, iron-requiring 
bacteria versus non-iron-requiring bacteria (34–38). It should be noted that the majority of these 
studies were conducted to evaluate the effects of iron supplementation versus deficiency. Few 
studies have characterized the effects of ID or IDA on the microbiota, and to our knowledge, 
most studies that have characterized the effects of ID on the microbiota were performed in the 
rodent model (38,39). As previously mentioned, the microbiota is known to have long-lasting 
effects on gastrointestinal, autoimmune, and metabolic diseases (5,6). Given the prevalence of ID 
(1) and that early microbial colonization of the GIT can have lasting effects on the health and 
development of infants (5,6,40), understanding the effects IDA has on the developing microbiota 
is imperative.  
In this study, young pigs were provided an iron-adequate or ID milk replacer through 
approximately 4 weeks of age followed by a period of dietary iron repletion. To evaluate the 
effect of ID on the microbiome, sequencing of bacterial 16S rRNA genes was utilized. We 
discovered through PCoA and PERMANOVA analyses that the microbiota of ID pigs differed 
significantly from that of CONT pigs in both AC and fecal samples at PND 32. In accordance 
with previous studies evaluating the microbiota of infants and pigs (8,41–43), the main bacterial 
phyla in our study included Bacteroidetes, Firmicutes, and Proteobacteria. Surprisingly, 
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Fusobacteria had higher representation than Actinobacteria, which is typically the fourth main 
phyla in pigs and human infants (8). This finding is comparable to Berding and colleagues, who 
also found higher levels of Fusobacteria in their pigs (44). At the genera level, our findings 
indicate that the ID diet created an environment in the GIT in which the growth of non-iron-
requiring, beneficial gut bacteria such as Lactobacillus and Bifidobacteria thrive, while most 
iron-requiring, potentially-pathogenic strains of bacteria were suppressed.  
The current study found that relative abundances of Prevotella and closely-related 
species, [Prevotella], were higher in both AC and fresh feces of ID pigs. Our results are 
comparable with a previous report demonstrating that fecal samples of anemic Kenyan infants 
provided a non-iron-fortified micronutrient powder displayed increased abundance of Prevotella 
compared with infants who received an iron-fortified micronutrient powder (34). Further, a study 
in Sprague Dawley rats observing the effects of varying iron supplementation methods by 
providing an ID control diet in comparison to various methods of iron supplementation also 
noted increased amounts of Prevotella  in ID animals (39). However, Pereira et al. (39) observed 
a decrease in [Prevotella] in ID rats, which is contrary to our observations. This inconsistency 
could be related to the difference in species, or due to the varying methods used to quantify the 
microbiota by Pereira and colleagues, which was noted as a limitation to their study (39).  
The observed higher relative abundance of Bifidobacteria in fresh feces and 
Lactobacillus in both AC and fresh feces in ID pigs compared with CONT pigs in our study is 
congruent with other studies across multiple species (38,44). It should be noted that most other 
researchers evaluated iron supplementation, and thus found that higher iron intake was related 
with decreased amounts of Bifidobacteria and Lactobacillus (36,45,46). This was expected, as 
the two genera are known to be among the few that are non- or low-iron requiring bacteria 
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(47,48). Interestingly, iron-requiring bacteria Escherichia/Shigella (49,50) were higher in feces 
of ID pigs compared with CONT pigs. Typically, potentially-pathogenic bacteria such as 
Escherichia/Shigella are decreased in low-iron environments. Further, it has been established 
that bacteria such as Bifidobacteria and Lactobacillus directly compete with Escherichia for 
resources (37,38). Given that the observed prevalence of Bifidobacteria and Lactobacillus were 
higher in feces of ID pigs, the increase of Escherichia/Shigella is even more confounding. To our 
knowledge, only one other study reported an increase in Escherichia in anemic animals (51), and 
it was related to the high prevalence of diarrhea. It has been accepted that some strains of 
Escherichia/Shigella are associated with diarrhea in infants (52). Fecal moisture content, 
expressed inversely as dry matter content, revealed that ID pigs had 50% more moisture in fresh 
feces compared with CONT pigs, thus it is possible that diarrhea was present, possibly associated 
with the higher levels of Escherichia/Shigella detected in ID pigs. It is also well established that 
ID and IDA can lead to diminished immune function and higher susceptibility to pathogens 
(53,54). Despite being iron-requiring bacteria, the greater susceptibility of ID pigs to illness may 
also contribute to the higher amount of Escherichia/Shigella observed. However, given that 
Escherichia/Shigella are opportunistic pathogens, the growth of these bacteria in ID pigs 
warrants future research to determine why they were increased so markedly in an ID 
environment.  
Similar to Escherichia  and Shigella, Bacteroides are potentially-pathogenic, iron-
requiring microbes, but have been recognized as having a beneficial relationship with the host 
when contained within the intestinal lumen (5,55). Bacteroides is also known to be one of the 
most abundant genera found in both pigs (8,43) and humans (56,57). As such, Bacteroides 
represented a large proportion of the bacterial makeup of CONT and ID pigs in AC contents, but 
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remained high only in the feces of CONT pigs, and was greatly decreased in feces of ID pigs. 
The difference in abundance of Bacteroides in the current study between AC and feces may be 
attributed to the amount of iron available between the two sites of the large intestine. Bacteroides 
is extremely proficient in its ability to scavenge for iron (58), which, although low in the 
proximal colon of the ID group, would have been comparatively more available than in the distal 
colon. Ultimately, it is unclear why the relative abundance of Bacteroides is only reduced in the 
feces of ID pigs compared with CONT pigs, but the subsequent decrease in Bacteroides in feces 
of ID animals, or increase in cases of iron supplementation, has also been noted elsewhere 
(34,38,44,59). No previous studies have evaluated the microbiota in AC, so future studies 
evaluating the regional abundances of Bacteroides in the context of iron status are warranted.  
Clostridium from the families of Clostridiaceae, Lachnospiraceae, and Ruminococcaceae 
were higher in the feces of CONT pigs compared with ID pigs. Few studies assessing the effects 
of iron on the microbiota have focused on the Clostridium genera, however, one study noted an 
increase in various strains of Clostridium in infants given iron-supplemented micronutrient 
powders compared with infants who were not iron supplemented (34). Further, Wang and 
colleagues compared the microbiota of breastfed versus formula-fed infants in the U.S. (5), and 
noted that levels of Clostridium were higher in formula-fed infants. It is well established that 
human milk is low in iron (60,61), and it is hypothesized that the iron in milk is bound to 
lactoferrin to prevent use by potentially-pathogenic bacteria and heighten iron bioavailability to 
the infant (62). Further, infant formula in the U.S. is supplemented with iron at 12 mg/L (47,63), 
and potentially-pathogenic members of the Clostridium genera are also iron-requiring bacteria 
(48). In the current study, CONT pigs were provided an iron-fortified milk replacer similar to 
human infant formula, whereas the ID pigs were provided a low iron formula with iron content 
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similar to that in porcine and human milk. Taken together, these findings complement the higher 
relative abundances of various Clostridium strains in the CONT group versus ID group.  
It is important to highlight that even though the ID group showed lower concentrations of most 
potentially pathogenic bacteria and increased levels of beneficial gut bacteria, the negative side 
effects known to be associated with IDA such as increased susceptibility to infection and disease 
(64), and altered cognitive development (65,66) outweigh any potential benefits on the 
microbiota. Due to the high amount of genera significantly altered in the ID group, we chose to 
speak mainly to those known to be effected by iron status. However, future research should be 
conducted to look into alterations in microbes not elucidated here. Samples from PND 61 were 
not analyzed for microbial composition. However, recovery of the microbiota of ID pigs near 
that of CONT pigs may be assumed due to the full recovery of VFA profiles in ID pigs compared 
with CONT pigs after a period of dietary iron repletion by consuming a common series of diets.  
Volatile Fatty Acid Composition 
Volatile fatty acids are the primary end-products of microbial fermentation in the hindgut 
(67). Thus, the diet and the composition of the microbiota play significant roles in VFA 
formation (7,68). At PND 32, we observed increases in total VFA concentrations in both AC and 
fresh feces in ID pigs compared with CONT pigs. Given that CONT and ID milk replacers 
differed only in the level of iron, a non-fermentable nutrient, it can be surmised that the 
differences in VFA profiles between CONT and ID pigs stem directly from the shift in the 
microbiota due to early-life iron deficiency. A previous study comparing the microbial and VFA 
profiles of European and rural African children found that increased amounts of bacteria such as 
Prevotella, known for their fermentative capabilities of insoluble fibers, led to increased VFA 
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concentrations (32). The ID pigs in this study displayed significantly higher relative abundances 
of Prevotella at PND 32 compared with CONT pigs, thus the higher levels of Prevotella and 
closely-related species could have contributed to the higher overall amount of VFA observed in 
the ID group. It has also been noted that VFA production via bacterial fermentation can lead to 
lower intestinal pH, subsequently increasing solubility of minerals such as iron and thereby 
improving their absorption (33,69). Further, Bougle and colleagues performed a study utilizing 
the Ussing chamber to evaluate iron absorption throughout the GIT in Sprague-Dawley rats. 
They concluded that the ascending colon could be a noteworthy location for iron absorption 
(lower absorption rates than in the duodenum, which is the main site of iron absorption, but 
higher than more distal parts of the small intestine) (70). Bougle also noted that VFA, especially 
propionate, can enhance this effect (70). Interestingly, absolute amounts of propionate were 
higher at PND 32 in ID pigs compared with CONT pigs in both AC and fresh feces in our study. 
Although we do not have direct measures of pH in AC and feces, we speculate that the higher 
amount of propionate and total VFA production observed in ID pigs could be a compensatory 
effect to counteract severe iron deficiency by allowing greater chances of any available iron to be 
absorbed. It should be noted that other studies evaluating VFA in the context of iron deficiency 
did not observe comparable effects to our study. Dostal et al. actually noted decreased amounts 
of VFA in a study evaluating the effects of iron deficiency and supplementation on the 
microbiota in Sprague-Dawley rats (38). However, Dostal and colleagues also found that VFA 
production between an ID and iron-sufficient group of rats were not significantly different from 
each other in a later study (35). These variations could stem from the dissimilarities in model, as 
the rat practices coprophagy. Pigs in the current study are largely separated from their fecal 
material, making the results seen more representative than rodent studies. Taken together, the 
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effects iron deficiency have on VFA profiles appears to vary across studies, which may require 
further investigation.  
Following dietary iron repletion throughout phase 2 of the study, VFA profiles of ID pigs 
recovered to levels comparable to those observed in CONT pigs by PND 61. Recovery of VFA 
profiles of ID pigs to match that of CONT pigs provides strong, though not definitive, evidence 
that consumption of a common series of iron-adequate diets by both groups allowed for 
stabilization of the microbiota following early-life ID. However, as microbial makeup and 
fermentation in the GIT are the driving factors of VFA profiles, it can be surmised that the 
microbiota of ID pigs is recovered to a profile near that of CONT pigs as well. Taken together, 
these findings suggest that early-life iron deficiency has a significant effect on the microbiota, 
and thus the VFA profile, and recovery of the microbiota is at least partially possible. However, 
future studies are necessary to fully characterize the microbiota after a period of early-life iron 
deficiency to establish if full recovery is possible, and how long repletion of iron in the diet is 
necessary.  
Conclusion 
Herein, a severely anemic pig model was created through dietary manipulation alone. We 
observed altered VFA profiles at the end of phase 1, with ID pigs displaying increased VFA 
production in AC and fresh feces. The microbiota was also significantly affected, and though 
greater differences were found in feces of ID pigs compared with CONT pigs, alterations in AC 
were elucidated in the separation of the two groups by PCoA and PERMANOVA analyses. 
Apart from the finding that Esherichia/Shigella abundances were greater in ID pigs, there tended 
to be lower relative abundances of potentially pathogenic bacteria such as Bacteroides and 
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Clostridium in ID pigs, and higher amounts of beneficial bacteria such as Bifidobacteria and 
Lactobacilli. Overall, these findings indicate that early-life iron deficiency effects the microbiota 
and, subsequently, VFA production and profiles. Further, that iron is an essential nutrient for 
proper development of the neonatal microbiota. VFA production and profiles were recovered to 
levels comparable to those seen in CONT pigs at study conclusion, thus it can be determined that 
the microbiota was recovered as well. However, future studies should seek to wholly 
characterize the influence of iron on the makeup of the microbiota after a time of dietary iron 
repletion to establish whether a full recovery is possible after an ID state. Further, to evaluate the 
long-term effects of altered microbial colonization due to early-life iron deficiency. The young 
pig proves to be an optimal translational model to study the effects of a micronutrient deficiency, 
specifically an iron deficiency, and how it will affect the development of the microbiota of both 
pigs and human infants. Further, it highlights a critical window during which adequate dietary 
iron intake is imperative to establish a customary microbiota. Lastly, future work should seek to 
establish the duration of dietary iron repletion needed to fully reverse the effects of early-life 
IDA.  
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4.6 TABLES 
Table 4.1. Relative abundances of bacterial phyla detected in ascending colon and 
fecal samples at PND321  
 Ascending Colon  Fresh Feces 
Phyla CONT, n = 6 ID, n = 7  CONT, n = 13 ID, n = 11 
Actinobacteria 0.24 ± 0.46 0.71 ± 0.44  0.71 ± 0.87 3.72 ± 0.94* 
Bacteroidetes 62.4 ± 5.05 56.3 ± 4.67  45.3 ± 3.17 43.9 ± 3.45 
Cyanobacteria 0.02 ± 0.02 0.02 ± 0.02  0.08 ± 0.05 0.05 ± 0.05 
Deferribacteres 0.00 ± 0.01 0.00 ± 0.01  0.00 ± 0.00 0.00 ± 0.00 
Firmicutes 23.9 ± 7.7 25.5 ± 7.55  44.0 ± 3.53 41.2 ± 3.84 
Fusobacteria 5.06 ± 2.27 4.77 ± 2.24  1.32 ± 1.43 1.90 ± 1.45 
Lentisphaerae 0.01 ± 0.01 0.02 ± 0.01  0.00 ± 0.01 0.02 ± 0.01 
Planctomycetes 0.00 ± 0.00 0.00 ± 0.00  0.01 ± 0.01 0.01 ± 0.01 
Proteobacteria 5.26 ± 3.53 10.2 ± 3.48  3.19 ± 0.96 6.80 ± 1.05* 
Spirochaetes 0.00 ± 0.01 0.02 ± 0.01  0.00 ± 0.01 0.02 ± 0.01 
Synergistetes 0.34 ± 0.15 0.06 ± 0.14  0.47 ± 0.16 0.34 ± 0.17 
Tenericutes 0.20 ± 0.13 0.13 ± 0.13  0.09 ± 0.10 0.28 ± 0.11 
Verrucomicrobia 0.07 ± 0.03 0.00 ± 0.03  1.33 ± 0.51 0.06 ± 0.55 
WPS-2 0.31 ± 0.20 0.07 ± 0.20  0.16 ± 0.15 0.11 ± 0.15 
Unknown bacteria 1.78 ± 0.34 1.93 ± 0.34  1.61 ± 0.60 2.17 ± 0.61* 
1Data are expressed as mean ± standard error of the mean (SEM) for each dietary 
treatment group. Main effects of dietary treatment (Diet; CONT vs ID) are presented. 
Abbreviations: CONT, control diet; ID, iron deficient diet; PND, postnatal day; SEM, 
standard error of the mean.  
*Within same intestinal segment and row, CONT and ID groups differ, P ≤ 0.05. 
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  Table 4.2. Relative abundances of bacterial genera detected in ascending colon 
contents at PND321  
Bacterial genus2 CONT, n = 6 ID, n = 7 P-value4 
Actinobacteria    
 Collinsella 0.05 ± 0.02 0 ± 0.02 0.036 
 Eggerthella 0.05 ± 0.02 0 ± 0.02 0.006 
Bacteroidetes    
 Alistipes 0.77 ± 0.19 0.29 ± 0.18 0.057 
 Bacteroides 27.91 ± 6.96 15.49 ± 6.45 0.209 
 Barnesiella 0.13 ± 0.05 0.01 ± 0.05 0.002 
 Butyricimonas  3.74 ± 1.37 1.00 ± 1.32 0.021 
 Odoribacter 4.08 ± 2.87 1.77 ± 2.86 0.074 
 Parabacteroides 11.87 ± 5.66 3.52 ± 5.58 0.042 
 Prevotella 1.48 ± 4.65 7.14 ± 4.58 0.010 
 [Prevotella] 3 1.83 ± 2.77 11.37 ± 2.65 0.020 
Firmicutes    
 Acidaminococcus 0.00 ± 0.70 0.90 ± 0.64 0.230 
 Anaerofilum 0.05 ± 0.02 0.01 ± 0.02 0.073 
 Anaerotruncus 0.10 ± 0.05 0.03 ± 0.05 0.034 
 Anaerovibrio 0.08 ± 0.06 0.01 ± 0.06 0.161 
 Blautia 1.33 ± 0.94 1.05 ± 0.91 0.632 
 Christensenella 0.07 ± 0.03 0.01 ± 0.03 0.069 
 Clostridium (Clostridiaceae)  0.32 ± 0.32 0.56 ± 0.31 0.548 
 Clostridium (Lachnospiraceae)  0.66 ± 0.20 0.18 ± 0.19 0.058 
 Clostridium (Ruminococcaceae) 0.09 ± 0.05 0.01 ± 0.04 0.160 
 Coprococcus 0.10 ± 0.04 0.08 ± 0.03 0.759 
 Dialister 0.00 ± 0.02 0.07 ± 0.01 0.001 
 Dorea 1.39 ± 0.66 1.05 ± 0.62 0.642 
 Epulopiscium 0.39 ± 2.13 2.54 ± 2.06 0.297 
 [Eubacterium] 0.51 ± 0.22 0.17 ± 0.21 0.190 
 Faecalibacterium 0.53 ± 0.57 1.50 ± 0.54 0.190 
 Lactobacillus 0.31 ± 2.25 5.99 ± 2.11 0.012 
 Lactococcus 0.29 ± 0.10 0.09 ± 0.10 0.354 
 Leuconostoc 0.34 ± 0.16 0.06 ± 0.15 0.413 
 Megaspheara 0.00 ± 0.07 0.14 ± 0.06 0.015 
 Mitsuokella 0.00 ± 0.23 0.32 ± 0.21 0.128 
 Oscillospira 2.20 ± 1.11 1.70 ± 1.08 0.519 
 Phascolarctobacterium 0.16 ± 0.08 0.02 ± 0.08 0.150 
 P-75-a5 0.14 ± 0.18 0.21 ± 0.18 0.765 
 Ruminococcus 0.14 ± 0.03 0.10 ± 0.03 0.304 
 [Ruminococcus]3 2.91 ± 0.49 0.79 ± 0.46 0.003 
 RFN20 0.00 ± 0.18 0.35 ± 0.16 0.134 
1Data are expressed as mean ± standard error of the mean (SEM) for each 
dietary treatment group. Main effects of dietary treatment (Diet; CONT vs ID) 
are presented. Abbreviations: CONT, control diet; ID, iron deficient diet; PND, 
postnatal day; SEM, standard error of the mean.  
2Only bacterial genera with mean relative abundance >0.05% were analyzed. 
Data are expressed as mean ± SEM. 
3Taxa that have brackets around the names are proposed taxonomies that 
Greengenes recommends based on the whole genome phylogeny but not 
officially recognized by Bergey’s manual of systematic bacteriology. 
4P-values for the main effect of early-life dietary iron status, which were arcsin 
transformed before analysis. 
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Table 4.2, continued.     
Fusobacteria    
 Fusobacterium 3.17 ± 1.21 2.23 ± 1.16 0.521 
Proteobacteria    
 Bilophila 0.14 ± 0.06 0.02 ± 0.06 0.019 
 Campylobacter 0.04 ± 1.12 2.31 ± 1.04 0.082 
 Desulfovibrio 1.15 ± 0.34 0.38 ± 0.31 0.101 
 Escherichia 0.75 ± 1.41 2.48 ± 1.36 0.199 
 Flexispira 0.03 ± 0.11 0.16 ± 0.11 0.068 
 Helicobacter 0.11 ± 0.38 0.54 ± 0.37 0.051 
 Pasteurella 0.07 ± 0.05 0.02 ± 0.05 0.977 
 Sutterella 1.53 ± 0.32 0.20 ± 0.29 0.011 
Synergistetes    
 Synergistes 0.25 ± 0.11 0.04 ± 0.10 0.173 
Verrucomicrobia    
 Akkermansia 0.07 ± 0.03 0.00 ± 0.03 0.006 
1Data are expressed as mean ± standard error of the mean (SEM) for each 
dietary treatment group. Main effects of dietary treatment (Diet; CONT vs ID) 
are presented. Abbreviations: CONT, control diet; ID, iron deficient diet; PND, 
postnatal day; SEM, standard error of the mean.  
2Only bacterial genera with mean relative abundance >0.05% were analyzed. 
Data are expressed as mean ± SEM. 
3Taxa that have brackets around the names are proposed taxonomies that 
Greengenes recommends based on the whole genome phylogeny but not 
officially recognized by Bergey’s manual of systematic bacteriology. 
4P-values for the main effect of early-life dietary iron status, which were arcsin 
transformed before analysis. 
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Table 4.3. Relative abundances of bacterial genera detected in fresh feces at 
PND321  
Bacterial genus2 CONT, n = 13 ID, n = 11 P-value4 
Actinobacteria    
 Bifidobacteria  0.01 ± 0.39 0.96 ± 0.43 0.041 
 Collinsella 0.05 ± 0.01 0.04 ± 0.01 0.490 
 Eggerthella 0.19 ± 0.08 0.01 ± 0.09 0.029 
 Rothia 0.07 ± 0.02 0.01 ± 0.02 0.011 
Bacteroidetes    
 Alistipes 0.53 ± 0.23 0.97 ± 0.25 0.244 
 Bacteroides 30.00 ± 7.17 1.06 ± 7.52 <0.001 
 Barnesiella 0.28 ± 0.22 0.18 ± 0.22 0.024 
 Butyricimonas 1.29 ± 0.52 1.46 ± 0.55 0.883 
 Odoribacter  2.13 ± 2.28 5.20 ± 2.42 0.193 
 Parabacteroides 2.51 ± 1.41 2.22 ± 1.43 0.520 
 Prevotella 0.90 ± 1.46 2.78 ± 1.49 <0.001 
 [Prevotella] 3 0.20 ± 1.84 9.99 ± 2.00 <0.001 
Firmicutes    
 Acidaminococcus 0.00 ± 0.07 0.26 ± 0.07 <0.001 
 Anaerofilum 0.04 ± 0.01 0.02 ± 0.01 0.053 
 Anaerotruncus 0.16 ± 0.04 0.13 ± 0.04 0.703 
 Blautia 1.67 ± 0.84 3.44 ± 0.91 0.189 
 Christensenella 0.18 ± 0.05 0.03 ± 0.06 0.001 
 Clostridium (Clostridiaceae) 2.44 ± 0.79 0.17 ± 0.86 0.010 
 Clostridium (Lachnospiraceae)   1.18 ± 0.37 0.55 ± 0.39 0.013 
 Clostridium (Peptostreptococcaceae)  0.09 ± 0.03 0.02 ± 0.03 0.053 
 Clostridium (Ruminococcaceae) 0.06 ± 0.02 0.01 ± 0.02 0.011 
 Coprococcus 0.10 ± 0.06 0.18 ± 0.06 0.017 
 Dialister 0.00 ± 0.02 0.11 ± 0.02 <0.001 
 Dorea 1.57 ± 0.56 1.57 ± 0.61 0.717 
 Enterococcus 0.08 ± 0.06 0.01 ± 0.06 0.341 
 Epulopiscium 1.46 ± 2.33 2.93 ± 2.37 0.134 
 [Eubacterium]  3.18 ± 1.15 0.06 ± 1.24 0.008 
 Faecalibacterium 0.37 ± 0.28 1.48 ± 0.30 0.005 
 Lactobacillus 1.10 ± 0.78 4.12 ± 0.85 0.001 
 Lactococcus 0.07 ± 0.10 0.20 ± 0.11 0.633 
 Leuconostoc 1.05 ± 0.49 0.04 ± 0.53 0.158 
 Megasphaera 0.00 ± 0.05 0.29 ± 0.05 <0.001 
 Mitsuokella 0.00 ± 0.05 0.23 ± 0.06 <0.001 
 Mogibacterium 0.04 ± 0.01 0.05 ± 0.01 0.124 
 Oscillospira 2.25 ± 0.81 5.47 ± 0.88 0.006 
 Phascolarctobacterium 0.07 ± 0.02 0.03 ± 0.02 0.485 
 p-75-a5 0.40 ± 0.17 0.03 ± 0.19 0.235 
 Ruminococcus 0.23 ± 0.06 0.29 ± 0.06 0.602 
1Data are expressed as mean ± standard error of the mean (SEM) for each dietary 
treatment group. Main effects of dietary treatment (Diet; CONT vs ID) is 
presented. Abbreviations: CONT, control diet; ID, iron deficient diet; PND, 
postnatal day; SEM, standard error of the mean.  
2Only bacterial genera with mean relative abundance >0.05% were analyzed. Data 
are expressed as mean ± SEM. 
3Taxa that have brackets around the names are proposed taxonomies that 
Greengenes recommends based on the whole genome phylogeny but not officially 
recognized by Bergey’s manual of systematic bacteriology. 
4P-values for the main effect of early-life dietary iron status, which were arcsin 
transformed before analysis. 
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Table 4.3, continued. 
Firmicutes, cont.     
 [Ruminococcus] 3.46 ± 0.52 1.77 ± 0.56 0.045 
 RFN20 0.00 ± 0.14 0.33 ± 0.15 0.039 
 Sharpea 0.00 ± 0.09 0.31 ± 0.10 0.003 
 Streptococcus 0.07 ± 0.03 0.01 ± 0.03 0.151 
Fusobacteria    
 Fusobacterium 0.09 ± 0.03 0.04 ± 0.04 0.209 
Proteobacteria    
 Bilophila 0.03 ± 0.02 0.10 ± 0.02 0.037 
 Campylobacter 0.09 ± 0.14 0.27 ± 0.15 0.527 
 Desulfovibrio 1.68 ± 0.29 1.07 ± 0.32 0.130 
 Escherichia 0.87 ± 0.99 4.62 ± 1.07 0.009 
 Shigella 0.01 ± 0.01 0.05 ± 0.01 0.004 
 Sutterella 0.12 ± 0.03 0.04 ± 0.04 0.197 
Synergistetes    
 Synergistes 0.35 ± 0.12 0.24 ± 0.13 0.753 
Verrucomicrobia    
 Akkermansia 0.13 ± 0.50 0.06 ± 0.54 0.010 
1Data are expressed as mean ± standard error of the mean (SEM) for each dietary 
treatment group. Main effects of dietary treatment (Diet; CONT vs ID) is 
presented. Abbreviations: CONT, control diet; ID, iron deficient diet; PND, 
postnatal day; SEM, standard error of the mean.  
2Only bacterial genera with mean relative abundance >0.05% were analyzed. Data 
are expressed as mean ± SEM. 
3Taxa that have brackets around the names are proposed taxonomies that 
Greengenes recommends based on the whole genome phylogeny but not officially 
recognized by Bergey’s manual of systematic bacteriology. 
4P-values for the main effect of early-life dietary iron status, which were arcsin 
transformed before analysis. 
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Table 4.4. Within sample bacterial diversity in ascending colon content and feces at PND321  
 Ascending Colon  Feces 
Alpha Diversity CONT, n = 6 ID, n = 7  CONT, n = 13 ID, n = 11 
Observed OTU’s 3161 ± 678.8 3035 ± 674.5  3120 ± 177.6 3739 ± 193.0* 
Shannon Index 7.46 ± 0.743 7.36 ± 0.739  7.22 ± 0.449 8.27 ± 0.474* 
Simpson Reciprocal 34.69 ± 14.875 27.65 ± 14.583  35.38 ± 14.024 48.720 ± 14.328 
Chao 1 6015 ± 1469.7 5677 ± 1462.4  6214 ± 395.0 6955 ± 429.4 
1Data are expressed as mean ± standard error of the mean (SEM) for each dietary treatment group. Main effects of dietary 
treatment (Diet; CONT vs ID) are presented. Abbreviations: CONT, control diet; ID, iron deficient diet; PND, postnatal 
day; SEM, standard error of the mean; OTU, operational taxonomic unit.  
*Within same intestinal segment and row, CONT and ID groups differ, P ≤ 0.05. 
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Table 4.5. Effect of iron status on volatile fatty acid concentrations in ascending colon 
contents1  
  Diet Pooled 
SEM 
 
Measure N2 CONT ID P-value3 
PND 32      
   Dry Matter, % 13 22.21 11.77 4.404 0.006 
 Total VFA Concentration, µmol/g DM 13 349.67 859.51 183.390 0.003 
Absolute Concentration, µmol/g DM      
      Acetate 13 197.97 566.36 110.770 0.002 
      Propionate 13 88.81 171.76 43.692 0.018 
      Butyrate 13 36.77 80.21 19.862 0.012 
      Valerate 13 8.98 20.16 4.234 0.025 
      Isobutyrate 13 7.53 9.14 1.643 0.314 
      Isovalerate 13 8.90 10.96 2.083 0.321 
Relative Profile, % of Total VFA      
      Acetate  13 56.24 66.95 1.186 < 0.001 
      Propionate 13 25.36 19.12 0.921 < 0.001 
      Butyrate 13 10.21 9.02 0.653 0.213 
      Valerate 13 2.42 2.28 0.276 0.720 
      Isobutyrate 13 2.617 1.102 0.296 0.002 
      Isovalerate 13 2.93 1.33 0.245 0.001 
PND 61      
   Dry Matter, % 20 16.44 19.36 5.536 0.382 
 Total VFA Concentration, µmol/g DM 20 647.34 610.93 197.330 0.678 
Absolute Concentration, µmol/g DM      
      Acetate 20 321.63 309.54 92.764 0.800 
      Propionate 20 194.44 163.66 61.291 0.363 
      Butyrate 20 105.31 109.83 39.239 0.753 
      Valerate 20 17.22 17.25 4.317 0.992 
      Isobutyrate 20 3.67 4.42 0.636 0.283 
      Isovalerate 20 5.77 6.24 0.730 0.585 
Relative Profile, % of Total VFA      
      Acetate  20 49.68 50.80 1.545 0.615 
      Propionate 20 29.27 26.09 1.664 0.194 
      Butyrate 20 16.56 18.01 1.191 0.316 
      Valerate 20 2.80 3.02 0.351 0.578 
      Isobutyrate 20 0.67 0.86 0.214 0.302 
      Isovalerate 20 1.05 1.23 0.347 0.497 
1Data presented as mean and pooled standard error of the means (SEM) for each dietary 
treatment group. Main effects of dietary treatment (Diet; CONT vs ID) are presented. 
Abbreviations: CONT, control diet; ID, iron deficient diet; PND, postnatal day; SEM, standard 
error of the mean; DM, dry matter basis; VFA, volatile fatty acid.  
2Total number of observations used. 
3P-values for the main effect of early-life dietary iron status. 
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Table 4.6. Effect of iron status on volatile fatty acid concentration in fresh feces1  
  Diet Pooled 
SEM 
 
Measure N2 CONT ID P-value3 
PND 32      
   Dry Matter, % 23 53.54 26.05 2.905 < 0.001 
 Total VFA Concentration, µmol/g DM 23 143.14 302.80 96.985 0.001 
Absolute Concentration, µmol/g DM      
      Acetate 23 81.48 199.58 66.553 < 0.001 
      Propionate 23 30.09 60.64 17.957 0.001 
      Butyrate 23 18.25 23.43 9.452 0.279 
      Valerate 23 2.78 5.20 1.158 0.007 
      Isobutyrate 23 4.11 6.18 1.173 0.060 
      Isovalerate 23 5.22 6.59 0.932 0.300 
Relative Profile, % of Total VFA      
      Acetate  23 47.65 63.12 1.540 < 0.001 
      Propionate 23 23.97 21.06 0.551 0.001 
      Butyrate 23 14.37 7.27 0.971 < 0.001 
      Valerate 23 2.68 2.22 0.232 0.165 
      Isobutyrate 23 4.47 2.62 0.440 < 0.001 
      Isovalerate 23 6.08 2.95 0.882 < 0.001 
PND 61      
   Dry Matter, % 20 23.64 22.63 1.762 0.612 
 Total VFA Concentration, µmol/g DM 20 350.03 387.22 71.801 0.719 
Absolute Concentration, µmol/g DM      
      Acetate 20 187.55 207.61 35.380 0.694 
      Propionate 20 85.38 95.52 23.764 0.834 
      Butyrate 20 53.35 60.59 11.541 0.663 
      Valerate 20 9.68 11.47 2.555 0.627 
      Isobutyrate 20 5.98 6.44 0.689 0.643 
      Isovalerate 20 8.08 8.60 1.055 0.738 
Relative Profile, % of Total VFA      
      Acetate  20 54.62 55.01 1.388 0.823 
      Propionate 20 22.51 22.41 2.252 0.956 
      Butyrate 20 15.28 15.16 1.026 0.934 
      Valerate 20 2.64 2.74 0.177 0.685 
      Isobutyrate 20 2.19 1.98 0.320 0.649 
      Isovalerate 20 2.99 2.70 0.485 0.681 
1Data presented as mean and pooled standard error of the means (SEM) for each dietary 
treatment group. Main effects of dietary treatment (Diet; CONT vs ID) are presented. 
Abbreviations: CONT, control diet; ID, iron deficient diet; PND, postnatal day; SEM, standard 
error of the mean; DM, dry matter basis.  
2Total number of observations used. 
3P-values for the main effect of early-life dietary iron status. 
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4.7 FIGURES 
 
Figure 4.1. Analyzed concentrations of iron expressed human and porcine milk, as well as in 
dietary treatments during both phases of the pig study. During phase 1, pigs were fed either a 
control (CONT) or iron-deficient (ID) milk replacer. The CONT treatment contained 21.3 mg/L 
(106.3 mg/kg) and the ID treatment contained 2.72 mg/L (13.6 mg/kg). The ID treatment closely 
resembled the average iron content of porcine milk (n=7; 1.06 mg/L) collected during a prior study 
(19), and is comparable to the iron concentration found in human milk (61,71). During phase 2, all 
pigs were fed a series of nutritionally-adequate, age-appropriate diets (180-300 mg/kg). 
Abbreviations: CONT, control diet; ID, iron deficient diet; PND, postnatal day.  
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Figure 4.2. Principal co-ordinate analysis of unweighted and weighted UniFrac distances 
generated from microbiota of AC and fresh fecal samples of piglets fed different diets. A: 
Unweighted; Generated from ascending colon contents of piglets fed CONT (n= 6) or ID (n= 7) 
diets. Adonis P = 0.003. B: Weighted; Generated from ascending colon contents of piglets fed 
CONT (n= 6) or ID (n= 7) diets. Adonis P = 0.035. C. Unweighted; Generated from feces of 
piglets fed CONT (n= 13) or ID (n= 11) diets. Adonis P = 0.001. D: Weighted; Generated from 
feces of piglets fed CONT (n= 13) or ID (n= 11) diets. Adonis P = 0.001. Abbreviations: CONT, 
control diet; ID, iron deficient diet.
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CHAPTER 5: SUMMARY AND CONCLUSIONS 
Early-life nutrition has a profound effect on the developing neonate, with some 
nutritional deficiencies leading to long-term alterations. This is the case for iron, as iron is an 
essential micronutrient for many biological processes throughout the body (1). Despite this, iron 
deficiency is the most pervasive micronutrient deficiency worldwide, with women of 
childbearing age and young children being the most susceptible (2,3). If left untreated, iron 
deficiency can quickly develop into iron deficiency anemia (IDA) which has more severe effects 
on the developing neonate. This is of heightened concern in the infant who is already susceptible 
to iron deficiency for reasons such as maternal iron deficiency, receiving low iron stores at birth, 
and heightened growth trajectories after birth (4,5). It should be noted that the timing and 
severity of iron deficiency experienced has an effect on the extent of detrimental outcomes 
correlated with iron deficiency (6,7). With iron repletion in the diet, some negative impacts of 
iron deficiency may be reversed, while other alterations persist. 
The overall aim of this study was to utilize the young pig as a translational model for the 
human infant to characterize the effects of early-life IDA during an iron deficient state. Further, 
to establish whether reversibility after iron repletion in the diet can compensate for early-life 
alterations due to IDA. The pig proves to be an optimal translational model for the human infant 
due to marked similarities between the two species, including physiological responses to an iron 
deficiency. Specifically, the young pig is similar to the human infant in gastrointestinal structure, 
microbial composition, and nutrient requirements (8), as well as having heightened growth 
trajectories after birth (9). As the young pig has similar physiology and nutrient requirements as 
the human infant (8), but relatively accelerated growth rates, it makes the pig an optimal model 
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for early-life nutrition research. Specific to iron deficiency, the young pig parallels the human 
infant in that porcine milk is low in iron, the pig acquires low levels of iron stores at birth, has 
increased iron demand due to heightened growth trajectories thereafter, and has immature iron 
absorption pathways until later in life (9).  
After randomization onto one of two dietary treatments, control (CONT) and iron 
deficient (ID) from postnatal day (PND) 2 to 32 (phase 1), we successfully created an ID young 
pig model. The ID group displayed markedly decreased hematocrit and hemoglobin values, 
signifying severe IDA by the end of phase 1 compared with CONT pigs. After being placed on 
an iron replete diet from PND 33-61, hematocrit and hemoglobin values of ID pigs recovered to 
concentrations not different than CONT pigs. Body weight was also significantly altered, with 
the ID group weighing strikingly less than the CONT group from PND 15 through study 
conclusion. Further, individual organ weights were affected. On an absolute basis, ID pigs had 
decreased liver and small intestine weights at both time points. Relative to body weight, ID pigs 
had a larger proportion attributed to the liver and small intestine at PND 61 compared with 
CONT pigs, suggesting compensatory gain. Interestingly, ID pigs had similar brain weights 
compared with CONT pigs on an absolute basis. On a relative basis, ID pigs had a larger 
proportion of weight attributed to the brain compared with CONT pigs, suggesting preservation. 
Protein and mRNA gene expression data for hepcidin and ferritin in the liver, and divalent metal 
transporter 1 (DMT1) in the proximal duodenum were largely inconclusive. Though gene 
expression did yield decreased hepcidin concentration in ID pigs compared with CONT pigs at 
PND 32, as expected to allow greater iron absorption. Further, subsequent recovery of hepcidin 
values to levels near the CONT group were found at PND 61. The microbiota of ID pigs was 
markedly different than that of CONT pigs as displayed by principal co-ordinate analysis and 
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permutational multivariate analysis of variance at PND 32. Furthermore, volatile fatty acid 
(VFA) profiles were significantly altered in the ID group, with increased absolute concentrations 
of acetate, propionate, butyrate, and valerate compared with CONT pigs at PND 32. By study 
conclusion, VFA profiles of ID pigs were similar to that of the CONT group. Microbial 
composition was not analyzed at PND 61. Given the recovery of VFA profiles in ID pigs, it can 
be assumed that the microbiota is somewhat recovered, though this is not definitive evidence. 
The current study has given insight to the impacts associated with an early-life iron 
deficiency. Overall, these data suggest that some, but not all alterations due to early-life iron 
deficiency can be reversed with iron repletion in the diet. However, suggested future directions 
should seek to characterize the length at which iron repletion is required before the effects, such 
as body weight, are ameliorated. Thus, a longer timeline should be incorporated. Further, future 
work should seek to fully characterize the microbiota after a period of dietary iron deficiency and 
subsequent iron repletion. Lastly, forthcoming studies should seek to provide definitive evidence 
as to reference values of iron related biomarkers in the porcine model via protein and gene 
mRNA expression for iron deficient and iron adequate states.   
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